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CHAPTER 1 
INTRODUCTION AND STATEMENT OF THE PROBLEM 
Cleft palate, a congenital defect, is the result of the failure 
of the palatine processes to meet and fuse during a specific time 
in embryological development. This malformation has long been known 
to man. In humans, cleft palate occurs approximately one in every 
800 live births (Grace, 1943). 
Early in the 1950 1 s, several investigators reported induction of 
cleft palates in the offspring of mice after maternal injection of 
corticoids. Baxter et al (1950) and Fraser et al (1951) established 
that the offspring of A/Jax mice were 100% susceptible to cleft 
palate when maternally injected with 2.5 mg. of cortisone acetate 
on day 11, 12, 13, and 14 of gestation. Chaudhry and associates (1967) 
reported that a single intramuscular injection of 10 mg. of cortisone 
acetate would induce 100% cleft palate if injected on 11.5, 12.5, or 
13.5 day of gestation in the same strain of mouse. Ingalls and Curley 
(1957) reported the same observation when hydrocortisone (cortisol) was 
injected instead of cortisone. 
Since these early studies, many investigations have been conducted 
in an effort to understand the mechanism of cleft palate induction 
of injected corticoids. 
Using radioactive cortisone or cortisol, in combination with 
autoradiographic and liquid scintillation techniques, studies have 
detected label in A/Jax maternal tissues (Nasjleti et al, 1967) and in the 
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fetal tissues, including the palatine processes (Marks, 1969, Schmitz, 
1970, and Waddell, 1971). In these studies, however, it was not 
established that the presence of label in the fetal and maternal 
tissues was the injected corticoid. 
Theoretically, cortisol or cortisone might produce cleft palate 
in at least four different ways: (1) by its direct action on the fetal 
maxillary and palatine processes; (2) by the direct action of their 
metabolites; (3) indirectly by altering the maternal and/or fetal 
physiology; or (4) by a combination of all of the above. 
Before it can be established that the cleft palate-inducing 
effect of cortisol or cortisone is due to a direct action on the 
fetal maxillary and palatal shelf tissue, it is necessary to deter-
mine that these two compounds reach the fetal tissues unaltered 
is significant levels after a 10 mg. dose to the mother. Likewise, 
if the teratogenic induction is affected by the direct action 
of the metabolites, one would expect to find a significant level 
of metabolites in the fetal maxillary and palatal tissues for 
a significant time interval after injection. Conversely, if 
significant levels of cortisol, cortisone or their metabolites are 
not found in the fetal jaws and palatal tissue or in any of the 
fetal tissues, it is unlikely that the cleft palate-producing 
action is affected by a direct action of these substances on the 
fetal tissues. The determination of cortisol and its metabolites 
has not been quantitatively or to any degree qualitatively studied 
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in A/Jax fetal tissues after injection of cortisol or cortisone 
on the day 12 of pregnancy. 
It is also important to determine the relative uptake and 
clearance rates of the various corticoids from the maternal and 
fetal tissues at sequential time intervals after injection. 
Considering the above parameters, the purpose of this study 
is as f o 11 ows: 
1. To determine whether or not the presence of tritium label 
in various maternal and fetal tissues is indicative of 
cortisol. 
2. To determine the quantitative uptake and relative clearance 
rates of total label and labeled corticoids in various 
maternal and fetal tissues at sequential post-injection 
time intervals on day 12 of pregnancy in A/Jax mice. 
3. To determine what percentages of label represent; (a) cortisol 
(b) cortisone, and/or (c) metabolites. 
4. To determine if there is a difference between the various 
fetal and maternal tissues in the content of total label. 
5. To determine if there is significant difference between 
the various maternal and fetal tissues in the percentages 
of labeled cortisol and/or its metabolites. 
6. To determine if the three fetal tissues vary in the uptake 
and elimination of tritium labeled cortisol and its 
metabolites. 
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CHAPTER 2 
REVIEW OF THE LITERATURE 
A. Cortisol Metabolism 
1. Cortisol Synthesis and Structure 
Cortisol (hydrocortisone) is principally synthesized 
in the mammalian adrenal cortex. Characterized by the twenty 
carbon pregnane nucleus, cortisol (also compound F) has a 
ketone at C3 and C20, a C4 C5 double bond, and a hydroxyl 
group at Cll and Cl7. The only difference between cortisone 
and cortisol is that cortisone has a ketone at Cll. 
Cortisol is biologically transported by the protein 
transcortin (Burton and Jeyes, 1968). In human plasma, 
cortisol is 90% protein bound and the remainder is free. 70% 
of cortisol metabolism occurs in the liver (Goodman and 
Gillman). Corticosterone is the chief glucocorticoid found 
in rodents (Waddell, 1971). 
2. Biologically Active Metabolites 
Oxidative and reductive changes (Berliner and Dougherty, 
1961) represent the principal reaction of the metabolism of 
cortisol, thereby producing other biologically active corticoids. 
Conversion of cortisol to cortisone by the enzyme llB-
hydroxydehydrogenase, is a reversible reaction in most 
mammals. This biotransformation can occur in the liver and in 
lymphocytes. Although this conversion produces a compound 
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(cortisone) with less anti-inflammatory effect, the potential 
remains due to the reversible characteristic. 
Methylation of cortisol at carbon 2 preserves its 
anti-inflammatory and gluconeogenic activities by inhibiting 
the conversion of cortisol to cortisone. The reaction can 
occur in peripheral, as well as in endocrine tissues. 
Cortisol loses its anti-inflammatory and gluconeogenic 
ability but gains androgenic activity when its side chain 
is oxidized and a Cl9 compound results. However, this 
transformation is not reversible. 
3. Biologically Inactive Metabolites 
Biologically inactive metabolites are those derivatives 
of cortisol with no known biological activity. This occurs 
mainly in the liver but can be performed by peripheral tissues. 
The only known exception is the formation of tetrahydro-
cortisol compounds which occurs only in the liver. 
Other conversions of cortisol to inactive compounds 
include substance E of Reichstein, substance U of Reichstein, 
dehydrocortisol, pregnane-llB, 17-dione, and 4-androstene-
llB-ol-3. These biotransformations are the result of 
combinations of oxidations, reductions, and saturation of 
the double bonds of hydroxyls, ketones, and double bonds 
characteristic of cortisol. These metabolites can be made 
water-soluble through conjugation in the liver, and secondarily 
in the kidney. Conjugation with glucuronic acid forms 
6 
glucuronides while conjugation with sulfate produces 
sulfate esters. Both water-soluble conjugates can be 
excreted through the kidney. The unconjugated metabolites 
will remain in the blood serum. 
B. Radioactive Cortisone and Cortisol Studies in Pregnant Experimental 
Animals 
Using wholebody autoradiography on mice, Hanngren, Hansson, 
Sjostrand, and Ullberg (1964) studied the relative uptake and 
distribution of intravenously injected 14c-cortisone and 
14c-cortisol. The strain of mice and the period of gestation 
were not reported. The animals were sacrificed at intervals 
varying from five minutes to twenty-four hours after the injection. 
No significant difference in the distribution pattern was 
found between the two injected substances and both were rapidly 
distributed in all tissues, including the fetal tissues. Both 
corticoids were reported to be evenly distributed in the fetal 
tissues, except for an accumulation in the adrenal cortex. 
Maternal tissues demonstrating a higher uptake of label than 
the blood included the liver, kidney, and salivary and lacrimal 
glands. The highest activity in these organs was reached 20 
minutes after injection. The uptake of both radioactive sub-
stances at a lower concentration. The time intervals for peak 
uptake of these substances in the fetal tissues was not reported. 
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Ethanol extracts from the maternal liver, intestine, kidney, 
brown fat, and urine, twenty minutes after injection of 14c-
cortisone, were analyzed by thin-layer chromatography. The 
chromatogram was developed in chloroform-acetic acid (90:10) 
and radioactivity was determined by autoradiography. Label 
at the cortisone level was reported only in the urine sample. 
Three other spots were noted in all specimens at the cortisone 
metabolite level. No attempt was made to identify these 
metabolites. The validity of this technique could be questioned 
on the basis of the variable energy spectrum and penetration 
ability of beta particles (Kisieleski, 1967), especially without 
the presence of a phosphor material in the chromatograph. 
Nasjleti, Avery, Spencer and Walden (1967) injected 10 mg. 
of tritiated cortisone acetate into pregnant A/Jax mice on 12.5 
days gestation. The mice were sacrificed at the following time 
intervals after injection: 30, 40, 50, and 60 minutes; two, three, 
four, six, and 24 hours; two and 6.5 days. Samples of maternal 
blood, liver, adrenals, spleens, kidney, thymus glands, and 
fetuses were taken to be evaluated by fluorometric, chromatographic 
(only plasma), radioautographic, and liquid scintillation techniques. 
Samples for liquid scintillation were suspended in a thioxotropic 
gelling agent after rapid hydrolysis of the tissue. Specimens 
used for chromatography were extracted according to Zaffaroni (1953), 
with iso-octane, sodium hydroxide, and chloroform. The extracts 
were chromatographically developed in toluene-methanol (70:30). 
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The results were listed without specifying the method of 
measuring the radioactivity. The radioactivity in the plasma was 
reported to have reached its peak forty minutes after injection. 
All of the tissues investigated at that time had a tritium 
concentration equal to or in excess of the plasma level. The 
conclusion was made that the tissues' tritium level "could not 
be said to reflect the blood content ... 11 At 6.5 days after 
injection, all of the tissues were void of radioactivity, except 
the liver. Radioautography of the embryos and placentas showed 
a concentration of activity on the maternal side of the placenta. 
Radioactivity in the fetal blood channels of the liver and 
heart did not appear until the 5.5 hour interval. Since 
chromatography on fetal tissues was not performed, specific 
identification of the activity was not made. No mention of the 
yolk sac was made. Because the samples counted for radioactivity 
in the liquid scintillation spectrometer were hydrolyzed rather 
than oxidized, the highly variable color quenching factor (Huebner 
and Kisieleski, 1970) must be considered in the evaluation of 
the data. 
Nasjleti (1968) reported that label was not found in the 
palatal shelf tissue. 
Levine, Yaffe and Black (1968) compared the fetal uptake of 
radioactive cortisol in A/Jax (cleft palate susceptible) and 
C-57 Black Mice (cleft palate nonsusceptible). Subcutaneous 
injections were made on day 11 gestation with 2.5 mg. of cold 
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carrier. The mice were sacrificed at intervals of 30, 60, 120 
and 240 minutes. For an unreported reason, different amounts of 
the 14c-A-Ring labeled cortisol was injected into the A/Jax 
mice (4.9 mg.) and the C-57 Black (7.3 mg.). The homogenated 
fetuses were placed directly into an aliquot of dioxane, 
liquoflur, and toluene for scintillation counting. 
Levine et al reported a similar rate of uptake of radio-
activity in both strains but a significantly higher amount in 
the A/Jax fetuses at all time intervals. The peak uptake of 
radioactivity by both fetal strains was in the 30 minute 
interval after injection. By extrapolation of the data back 
to zero, they showed that the two strains had similar disappearance 
rates of the labeled cortisol. From this, the conclusion was 
made that difference in susceptibility between the two strains 
was not due to variation in placental transport but due to 
differences in metabolism and/or binding by the fetuses. 
The data presented in this report is questionable, due to the 
difference in the injected dosage to each strain of mice and 
due to the variability caused by the color quenching when 
tissue samples are added directly to the scintillation fluor 
(Huebner and Kisieleski, 1970). 
In an intriguing article by Beitins, Kowarski, Shermeta, 
Delemos, and Migeon (1970), three pregnant ewes were continuously 
infused with 14c-cortisol while simultaneously infusing their 
10 
fetuses with 3H-cortisol in utero. The fetuses were infused 
by catheters through the common carotid artery, and a catheter 
was placed into the external jugular vein for withdrawing blood 
samples. The ewes had catheters for infusion placed in the 
external jugular vein while blood samples were drawn from the 
opposite jugular vein by venipunctures. After surgical placement 
of these catheters and the animal recovery, the double constant 
infusion of the radioactive cortisols began. Blood samples 
(maternal and fetal) were withdrawn every 15 minutes for three 
hours. The plasma was extracted with ethanol and the 3H-cortisol 
separated by paper chromatography. The radioactivity was 
measured in a liquid scintillation counter. 
The uptake of the fetal cortisol in the maternal blood 
was measured and corrected relative to the blood flow. A 
similar treatment of data from the fetal blood samples was made. 
Beitins et al reported a net transfer rate of the hormones 
across the placenta in both directions but of different magnitudes. 
There appeared to be a significant barrier for the movement 
of maternal cortisol to the fetus, thus allowing the fetus to 
maintain lower concentrations of cortisol for independent 
homeostatic regulation. 
A significant amount of label on autoradiographs in the 
fetal palatine processes on the twelfth day of gestation in 
A/Jax mice was reported by Marks (1969). He injected 2.5 mg. 
of unlabeled cortisone acetate intramuscularly thirty minutes 
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prior to a second injection of tritiated cortisol. The animals 
were sacrificed five hours after the second injection. Marks 
reasoned that the first injection of cortisone-acetate would 
overload the receptors for the metabolism of cortisone which 
would allow the tritiated cortisol to circulate freely and 
therefore increase its chances of finding its way to the fetus. 
Dodds (1971) found that this "loading dose" had just the opposite 
effect. 
Studying the specimens prepared by Marks, Schmitz (1970) 
reported a significantly higher grain count in the palatal 
processes in fetuses taken from the left uterine horn than 
those from the right. Marks had reported this same observation. 
Schmitz also reported a significant variation between placental 
and fetal tissues obtained from different mothers, explaining 
this variation by differences in maternal vascularity. 
Dodds (1971) compared the uptake of tritiated cortisol when 
injected in A/Jax mice on the 12th day of gestation with a 2.5 mg. 
cortisone acetate 11 loading dose" and without a "loading dose." 
All animals were sacrificed one hour after injection and the 
following tissues were removed: a. maternal tissues-- blood, liver, 
spleen, kidney, adrenal, heart, tongue, brain, and palatal mucosa; 
fetal tissues--liver, heart, jaws, tongue and brain. Each dry-
weighed tissue sample was oxidized in a Packard Tri-Carb Sample 
Oxidizer. 
The activity of the scintillation fluor containing the tritium 
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from the sample was then counted in a Beckman DPM 100 ambiant 
temperature liquid scintillation counter. Dodds reported no 
significant variation in the different maternal tissues (except 
higher in the liver) and no variation in the various fetal 
tissues. The maternal tissues were significantly higher than 
the fetal tissues. He also found that the loading dose hinders 
rather than improves the uptake of label. A comparison of 
placentas from the right and left sides were reported to have 
no significant difference in labeling. Dodds not only contributed 
the above results, but helped establish quantitative use of 
the Tri-Carb Oxidizer in conjunction with liquid scintillation 
for further use in the field of teratology using low energy 
radioisotopes. 
Waddell (1971), using wholebody autoradiograms, studied the 
distribution of 14c-cortisone in pregnant A/Jax mice. In this 
study, the following factors were varied: 1. The gestation 
periods at the time of injection were 7.5 days, 8.5, 9.5, 10.5, 
11.5, and 18.5 days. 2. The dosage of the injected cortisone 
ranged from 5-10 uCi of 14c-cortisone. 3. The time intervals 
after injection that the animals were sacrificed included one, 
three, nine, and 24 hours. 
Generally, Waddell found little variation in the autoradiograms 
between the different stages of gestation. He reported the highest 
concentration of radioactivity in the maternal bile, liver, 
intestinal contents, and the kidney. At all time intervals, the 
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concentrations of radioactivity in the fetuses were lower 
than the pregnant female. The fetal tissues reportedly showed 
a rather even distribution with no greater amounts in the 
palatal buds. He did emphasize the accumulation of radioactivity 
surrounding the embryo in all gestation periods past twelve 
days. With closer observation, Waddell found the accumulation 
to be due to the uterine luminal fluid between the endometrium 
of the mother and yolk sac. With thin-layer chromatography of the 
uterine fluid superimposed on X-ray film, he reported radio-
activity in the cortisone, the hydrocortisone (cortisol) and 
between the origin cortisol. The results from this single 
chromatogram of 12.5 day pregnant mouse sacrificed three hours 
after injection should be considered a pilot study rather than 
as a definitive finding. Waddell did not use chromatography 
on the other tissues. Since the fetal tissues were continuously 
lower, he concluded that the yolk sac is the cause of the difference 
either from a metabolic or an absorptive stand point. 
Waddell also tested 14c labeled hydrocortisone (cortisol) 
corticosterone, and progesterone under the same experimental 
model. The results also showed an "intense accumulation of 
radioactivity in the uterine luminal fluid. 11 He resolved that 
the mechanism is not specific for cortisone. 
In a comparative study between A/Jax and C-57 BL mice, 
(Reminga and Avery, 1972), the differential binding of 14C-
cortisone was examined. On day 12.5 of gestation, each pregnant 
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mouse was administered 2.5 mg. of cortisone acetate intra-
peritoneally plus 5 uCi of 14c-cortisone. Thirty minutes 
after the injection, the maternal liver, fetuses, and placentas 
were removed for the study. From the homogenized tissues, 
the unbound and tissue bound radioactivity was removed by 
differential extraction and centrifuging. Measurement of the 
radioactivity was accomplished by liquid scintillation. 
They reported that the differences in radioactive concentration 
between the two strains of mice were not significant except 
for that bound in the fetuses. The ratio of the bound to un-
conjugated steroid was twice as high in the A/Jax strain as 
in the C-57 Black mice. Their data (in cpm/gm.) showed a 
significant lower uptake of the three corticoids by the 
fetuses than by their maternal counterparts. 
Reminga and Avery referred to the work by Fraser et al (1954) 
for support of their method that a single intraperitoneal 
injection of cortisone would induce 100% cleft palates in A/Jax 
mice on the 12.5 day of gestation. Fraser et al injected 2.5 mg. 
(10 mg. total) of cortisone on four successive days beginning 
with day 11 of gestation to induce 100% cleft palate. Chaudhry 
et al reported that a 10 mg. dose of cortisone was necessary 
to induce 100% clefts injected intramuscularly on day 12.5 and 
only 76% of injected intraperitoneally on the same day. 
To the author's knowledge, no study has reported a single 
2.5 mg. dose of cortisone to be highly teratogenic to A/Jax mice. 
A. Mice 
CHAPTER 3 
MATERIALS AND METHODS 
Segregated A/Jax mice were obtained from Jackson Laboratory 
in Bar Harbor, Maine. A total of 12 males and 36 female mice, 
twelve weeks old, were used in this study. 
B. Feeding and Environment 
An environmental control room in the animal care facility 
was used, which maintained a constant temperature and humidity. 
A day/night cycle was maintained by automatically turning the 
lights on at 6:00 a.m. and off at 6:00 p.m. Standard Purina 
Rat Chow and tap water were given ad libitum. 
C. Mating 
Prior to mating of the A/Jax mice, all animals were placed 
in separate cages for conditioning to the environment, for 
two months. At the end of this period, mating commenced. 
One female was placed in a cage with a single male at 6:00 p.m. 
The female was then checked for the presence of a vaginal plug at 
8:00 a.m. on the following morning. At this time, all females and 
males were segregated until 6:00 p.m. that evening when they would 
again be mated. When a vaginal plug was found, the mouse was 
weighed and that day recorded as day zero. Since ovulation usually 
takes place shortly after midnight (Gruneberg, 1952) and copulation 
15 
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any time afterwards, an unavoidable error of 8 hours or less 
must be realized. The mouse was again weighed at 8:00 a.m. on 
day 12. If a weight gain of two grams or more was measured, 
the mouse was considered pregnant and then injected with the 
tritiated cortisol/cortisone solution to be described. 
o. Solution Preparation and Administration 
Cortisol-1, 2-3H from Amerhsam Searle, Chicago, Illinois, was 
obtained in a 9:1 v/v benzene/ethanol solvent and possessed 
a specific activity of 1 mCi/3ml. One-half hour before the 
injection, the solution was prepared as follows. A 0.3 ml. 
aliquot, containing 100 uCi of 3H cortisol by the manufacturer's 
standards, was aspirated from the stock solution with a tuberculin 
syringe. One-half of this aliquot was placed directly into 50 ml. 
of scintillation fluid (permafluor II, Packard Instrument Co., 
Inc. Downers Grove, Illinois) for the purpose of checking the 
activity of the stock solution. The remainder of the stock 
solution containing approximately 50 uCi of 3H-cortisol was 
placed in a vial and evaporated almost to dryness by an indirect 
air stream. This residue, containing the 3H-cortisol, was 
redissolved in 0.2 ml. of normal saline. 0.4 milliliters of 
cortisone acetate* containing 10 mg. of cortisol was added and 
mixed with the 3H-cortisol. This solution was then injected in 
equal volumes, into the rear leg muscles of each pregnant mouse. 
*Upjohn Company Kalamazoo Mich. 
E. Dissection and Obtaining Samples 
The mice were sacrificed with a single sharp blow to the 
occiput and immediately decapitated. Four animals were sacrificed 
at each of the following post-injection intervals: 0.5, 1.0, 
1.5, 2.0 and 3.0 hours. One pregnant mouse was sacrificed at 
six hours post-injection. The maternal livers, brains, adrenal 
glands, placentas, and yolk sacs were excised. The fetuses 
were incised into three segments, the face and jaws, the remainder 
of the head, and the torso. The placentas, yolk sacs and three 
fetal segments obtained from each mouse were pooled separately 
so that there were eight tissue specimens obtained from each 
animal: liver, brain, adrenal gland, placentas, yolk sacs, fetal 
face and jaws, remainder of fetal heads, and fetal torsos. It 
should be noted that Reichert's membrane is a part of the yolk 
sac at this stage of development (Calarco et al, 1966 and King, 
1971). With the exception of the liver, each of the eight 
tissue specimens were divided into two samples: (1) Series A 
for combustion and liquid scintillation, (2) Series B for 
extraction, chromatography, combustion, and liquid scintillation. 
The total liver was too large, so random specimens were excised 
from the various lobes and were divided into two samples as above. 
Wet weights of all the samples were obtained and recorded in 
milligrams as was the total liver. 
F. Combustion and Scintillation Technique 
The samples for combustion were placed on pre-weighed filter 
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paper (Whatman #1 filter paper, diameter 4.25 cm.) weighed, and 
permitted to dehydrate in the room atmosphere. They were then 
made into pellets, oxidized in a Packard Tri Carb Sample Oxidizer, 
Model #305 at Argonne National Laboratory, which burns the 
specimen completely to tritiated water and carbon dioxide in an 
oxygen atmosphere (Rapkin and Reich, 1972). The water, containing 
the tritium from the sample, was collected in a scintillation 
vial containing 15 ml. of scintillation fluid following a 
nitrogen purge of the chamber. The vials were then counted in a 
Packard Liquid Scintillation Spectrometer, Model #3375. All 
vials were counted twice for five minutes each and recorded in 
counts per minute. 
G. Extraction Technique 
Extraction of Series B samples with acetone for thin-layer 
chromatography was performed according to Burton (1968) with 
several modifications in the following manner. The tissues were 
first weighed and then manually homogenized in 0.2 ml. of cold 
saline solution in separate ground glass homogenization tubes. 
The homogenate was then extracted three times with acetone (0.5 
ml./100 mg. of tissue). To ensure complete extraction, the tissues 
were again homogenized for five minutes after the addition of 
acetone. Each extracted solution was poured through pre-acetone-
wetted filter paper into a collection tube. One more volume of 
acetone was used to rinse the homogenization tube and pestle. 
The filter paper was washed with a final volume of acetone. 
l 
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H. Chromatography Procedure 
The acetone extracted solutions were evaporated to dryness with 
an indirect air stream. The extracts were then redissolved in 
chloroform (.2 ml./100 mg. of extracted tissues). 50 Lamda each, 
of these solutions, were spotted separately on a silica-gel 
thin-layer chromatography sheet (Chromar 500 thin-layer chroma-
tography sheets) which contained ultraviolet phosphors and had 
been prewashed in chloroform. Also spotted with each separate 
tissue spot, was 15 lamda of a carrier solution (Bush, 1961) 
composed of a mixture of five mg. of each of the following 
steroids dissolved in 10 ml. of chloroform: cortisol, cortisone, 
corticosterone, 11-dehydrocorticosterone, and progesterone. 
The thin-layer sheets were developed in chloroform/glacial acetic 
acid/distilled water (90:10:1), (Stahl, 1962). The 1.0 per 
cent distilled water was added to reduce tailing if overloading 
of the layer occurred (Stahl, 1969). After allowing the front 
to advance 15 cm., the chromatogram was air-dried, viewed under 
ultraviolet light, and the spots outlined with a soft lead 
pencil. The spots were identified as specific steroids by 
utilizing a mix of the five known steroids mentioned above 
on each chromatography sheet. A photostatic copy of the chromatogram 
was made for reference. The chromatogram was then cut into 
sections so that each section contained one identified steroid 
spot or a spot representing unknown metabolites. Each section 
was then wrapped in Whatman #1 filter paper and made into pellets. 
Each coded pellet was combusted in the Packard Tri-Carb Sample 
, 
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Oxidizer by liquid scintillation. Each section was coded and 
recorded on the photostatic copy of the outlined chromatogram. 
Fifty lamda of each extract solution (a volume equal to the 
used in the chromatograph spotting) was placed on a filter paper, 
combusted, and counted. Thus, a total activity in counts per 
minute (cpm) was determined for the aliquot of each extract 
solution which was used in chromatography. The activity of 
each spot (identified steroid) on the chromatogram was counted 
and recorded as a per cent of the total activity for that extract. 
I. Determination of Efficiency of Extraction Method 
The combusted samples of each tissue in Series A yielded a 
cpm/mg. value for each tissue at each time interval. The 
weights of all the samples in Series B were also weighed and 
recorded. The filter papers used to filter each tissue extract 
which contained the tissue residues were combusted and counted. 
Thus, the cpm of those filter papers containing the residues, 
divided by the cpm/mg. of Series A, times the mg. of Series B 
extracted, times 100 yielded the per cent of the label that was 
not in the analyzed extract. 
J. Accuracy of Manufactured 3H Cortisol Solution 
The stock solution containing the 3H cortisol was checked for 
specific activity in the scintillation counter and the purity of 
the 3H cortisol was checked with chromatographic and scintillation 
, 
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procedures similar to those used above in the Series B samples. 
K. Summary of Total Combustion Procedures 
A total of 2,975 samples were combusted and counted by liquid 
scintillation. 
L. Reporting of Data 
Series A samples are reported in disintegrations per minute 
per milligram (DPM/mg.). The DPM is calculated from the counts 
per minute of the sample (less background) and the efficiency 
of the Packard Liquid Scintillation Spectrometer by the following 
formula: (Kisieleski, 1971). 
Counts per minute 
Disintegrations per minute = 
Efficiency x 100 
The DPM was then divided by the milligrams of tissue in that 
sample. 
Tritiated toluene was used as a reference standard for 
determining the efficiency. Background was determined by counting 
blank vials before counting the samples. 
Series B samples are reported as per cents of the total 
counts per minute in the 50 lamda of tissue extract spotted. 
M. Analysis of Data 
Data was analyzed by the analysis of variance (between-within). 
L 
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The analysis was computed by an International Business Machine 
systems Control Model #1130. Statistical significance was 
determined at the 0.05 and 0.01 level of significance as 
indicated in the analysis of variance tables (ANOVA). 
The K value was computed for each analysis of variance 
problem from which the means were compared and ranked for signi-
ficance (P .05). 
The ANOVA Tables printed by the computer have the following 
coded words: COUNTS represent disintegrations per minute per 
milligram; ADRENL represent the maternal adrenal gland; PLACEN 
for the placenta; VLK SC for the yolk sac; CORTISOL for cortisol; 
CORTSON for cortisone; UNDMET for undetermined metabolites; 
STD for standard deviation. 
The pregnant mouse sacrificed at six hours post-injection 
was not included in the data analysis. This data was the result 
of a pilot study to determine what the effect of a longer post-
injection time interval might be. 
CHAPTER 4 
FINDINGS 
A. comparison of Disintegrations Per Minute Per Milligram (DPM/mg.) 
Between All Maternal and Fetal Tissues at All Post-Injection Time 
Intervals 
The counts per minute (CPM) obtained from liquid scintillation 
measurements for all maternal and fetal tissues at all post-
injection time intervals were 10 times greater (minimum) than 
background. This data was then converted to DPM/mg. as previously 
described (page 21). Background counts averaged 25-32 CPM. 
The efficiency of the oxidizer ranged from 35 to 40 per cent. 
The following findings were determined to be significant 
and are shown in ANOVA Tables 1 through 5 and Figure 1. The 
maternal liver was higher in tritium content than all other tissues 
at all post-injection time intervals except for the yolk sac and 
the placenta at the 3.0 hour interval. The placenta and yolk 
sac were higher in tritium than all fetal tissues except at 
the 1.5 to 2.0 hour interval and the 1.5 hour interval respectively. 
The yolk sac tritium content was higher than the placenta at the 
1.0 and 2.0 hour interval. All three fetal segments were not signi-
ficantly different at any of the post-injection time intervals. 
The maternal brain was significantly lower than all tissues except 
the fetal head and torso at the half hour and one hour intervals. 
The peak uptake of tritium (DPM/mg.) in the maternal adrenal, 
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brain, and liver was at the 0.5 time interval (ANOVA Tables 6 
through 9). However, the placenta, yolk sac, and the three 
fetal segments reached a maximum level of tritium beginning at 
the 0.5 hour and maintained this level until the 2.0 hour 
post-injection interval (ANOVA Tables 9, 10, and 11 through 
13 respectively). 
B. Per Cents of 3H-Cortisol, 3H-Cortisone, and 3H-Metabolites 
All reported per cents of 3H-cortisol, 3H-cortisone, and 
3H-metabolites represent CPM of two (minimum) times greater 
than background. The measured CPM in the chromatographic 
zones of corticosterone, ll-dehydrocorticosterone, and progesterone 
were not significantly above background. These zones were not 
reported in the data or included in the analysis of variance 
tables. 
Tritiated metabolites which remained at the origin are 
reported as ORIGIN in the ANOVA Tables. This group of metabolites 
represents the conjugated corticoids as previously discussed. 
In the type of thin-layer chromatography used (adsorption), these 
water soluble polar metabolites are not moved by the chloroform 
solvent (Scott, 1969). 
The remainder of unidentified metabolites occupied the 
chromatographic zone between the origin and cortisol. This group 
of metabolites will be referred to as the undetermined metabolites 
(UNDMET) in the ANOVA Tables and UNO. Metabolites in all Figures. 
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Significant amounts of tritiated cortisol, cortisone, 
undetermined metabolites, and origin were found in all tissues 
analyzed including the three fetal segments. 
The percentages of each tritiated corticoid within each tissue 
are compared in ANOVA Tables 14 through 45. These per cents 
are graphed for each tissue in Figure 2 through 9. 
The technique of reporting data in per cents was most useful 
for studying trends within each tissue. However, the per cents 
should be differentiated from actual amounts of radioactivity. 
For example, ANOVA Table 14 reports that the per cent of cortisol 
in the fetal head did not significantly change between the five 
time intervals. If the mean per cents for each time interval 
were converted to DPM/mg. (multiplied times that tissue's total 
DPM/mg. at the corresponding time intervals), and plotted 
accordingly, this graphed data would not be a straight horizontal 
line. Instead this line would parallel the total DPM/mg. graph, 
Figure 2 for the head, except at a lower level. 
C. Per Cents of 3H-Corticoids Within the Fetal Tissues Compared 
The percentage of cortisol within each of the three fetal 
segments did not significantly change between the post-injection 
time intervals (ANOVA Tables 14 through 16). However, the 
percentage of metabolites within the fetal segments did significantly 
change. 
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Cortisone within the fetal head, showed only a significant 
decrease between the 0.5 time interval and the 3.0 hour interval. 
The cortisone within the fetal jaws showed a significant decrease 
from the 0.5 and 1.5 time intervals to the 2.0 and 3.0 hour intervals. 
The percentage of cortisone within the fetal torso more closely 
followed the cortisone pattern in the head with the exception 
of an additional significant decrease from the 0.5 hour to the 
2.0 hour interval (ANOVA Tables 17 through 19). 
The percentage of undetermined metabolites within the 
three fetal segments showed no significant changes (ANOVA 
Tables 20 through 22). 
The greatest variation within the fetal tissues, was shown 
by the origin metabolites (ANOVA Tables 23 through 25). These 
metabolites increased in percentage from the 0.5, 1.0 and 1.5 
hour interval to the 2 hour interval in the fetal head. These 
are the same intervals in which the DPM/mg. was significantly 
decreasing. Both the fetal jaws and torso showed a significant 
percentage increase in the origin metabolites between the 0.5 
to the 3.0 hour interval. These were also the time intervals 
that the fetal jaws and torso demonstrated significant decreases 
in the DPM/mg. 
The percentage of cortisone was significantly higher in the 
torso than in the fetal head and jaws at the 2.0 hour interval 
(ANOVA Table 34). This was the only time interval when the per cent 
of a corticoid within the fetal tissues was significantly different 
f 
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between the three segments. 
o. Per Cents of Tritiated Corticoids in Maternal Tissues Compared to 
Fetal Tissues 
For most time intervals, the percentage of corticoids within 
fetal tissues were significantly similar to those in the yolk sac 
and placenta with some exceptions. The percentage of cortisone 
within the placenta was significantly lower than the per cent 
in the fetal torso at the 0.5, 1.0, 1.5, and 2.0 hour intervals 
(ANOVA Tables 31 through 35). The placenta had a greater per 
cent of undetermined metabolites than the fetal jaws at the 
2.0 hour interval (ANOVA Table 39). 
The yolk sac was significantly different from fetal tissues 
at only one interval. The per cent of cortisone within the 
yolk sac was lower than in the fetal jaws (ANOVA Table 34) at 
the 2.0 hour interval. 
The placenta and yolk sac were significantly different 
in the per cent of a 3H-corticoid in only one instance. The 
placenta had a greater per cent of cortisol than did the yolk 
sac at the 1.0 hour interval (ANOVA Table 27). 
The per cents of 3H-corticoids within the maternal liver 
was significantly different from per cents of similar 3H-corticoids 
in all other tissues analyzed at many time intervals. However, 
at all time intervals when the liver 1 s corticoids were different 
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from those within the placenta and yolk sac, the liver corticoids 
were also significantly different from those in all three 
fetal segments. 
Another very important finding to be discussed was noted 
at the 3.0 hour interval. There was no significant difference 
between the maternal and fetal tissues in the separate per cents 
of a. cortisol, b. cortisone, and c. undetermined metabolites 
(ANOVA Table 30, 35, and 40 respectively). Only the per cents 
of origin metabolites had significant differences between the 
liver and all other tissues (ANOVA Table 45). 
E. Efficiency of Extraction Techniques 
The filter papers used in filtering the extracted tissue 
homogenates were combusted, counted in the scintillator, and 
recorded in cpm/mg. of tissue samples which were extracted. These 
values were divided by the cpm/mg. values of the combusted 
tissue of the Series A samples and multiplied by 100. This 
yielded the percentage of unextracted label of the tissues and 
varied between 15-19%. Thus, the percent of extraction of the 
total label in all the tissues varied between 81% and 85%. 
F. Purity and Accuracy of the 3H-Cortisol Stock Solution 
Thin-layer chromatography of the stock solution of cortisol-1, 
2-H3, was performed to test the purity. 93% of the counts were 
found in the cortisol zone. The remainder was divided between 
three areas, the origin, between cortisol and the origin, and at 
the endpoint of the solvent front. 
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couNTS 
ANOVA TABLE 1 
.5 HR 
SOURCE OF 
VARIATION 
DEGREES OF 
FREEDOM 
SUM OF 
SQUARES 
MEAN 
SQUARE 
DECISION 
F-RATIO CONCERNING Ho 
eEnJEEN 
TISSUE 
WITHIN 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PLACEN 
YLK SC 
HEAD 
JAWS 
TORSO 
MEAN 
3082.39 
222.99 
13307.25 
2441.45 
3289.25 
1143.73 
1364.20 
873.45 
7 
23 
30 
REJECTED 
494070969.25 70581567.09 202.75 
SIGNIFICANT 
(P<.Ol) 
8006754.76 348119.77 
502077724.37 
COMPARISONS OF MEANS K-VALUE 995.03 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
MEAN 
DIFF. 
1058.05 BRAIN -LIVER 13084.25 BRAIN -HEAD 920.73 
847.79 
650.45 
640.94 
490.75 
270.28 
220.46 
206.85 
15.25 LIVER -TORSO 12433.80 PLACEN-YLK SC 
623.36 LIVER -HEAD 12163.51 BRAIN •TORSO 
326.75 LIVER -JAWS 11943.05 ADRENL•PLACEN 
987.50 LIVER -PLACEN10865.80 JAWS ·TORSO 
134.63 AORENL-LIVER 10224.85 HEAD ·TORSO 
253.45 LIVER -YLK SC10018.00 HEAD -JAWS 
48.43 BRAIN -YLK SC 3066.25 AORENL•YLK SC 
ADRENL-BRAIN 2859.40 
YLK SC-TORSO 2415.80 
BRAIN -PLACEN 2218.45 
AORENL-TORSO 2208.95 
YLK SC-HEAD 2145.51 
ADRENL-HEAD 1938.66 
YLK SC-JAWS 1925.05 
ADRENL-JAWS 1718.19 
PLACEN-TORSO 1568.00 
PLACEN-HEAD 1297.71 
BRAIN -JAWS 1141.20 
PLACEN-JAWS 1077.25 
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couNTS ANOVA TABLE 2 
1. 0 HR 
soURCE OF 
VARIATION 
DEGREES OF 
FREEOOM 
SUM OF 
SQUARES 
MEAN 
SQUARE 
DECISION 
F-RATIO CONCERNING Ho 
BETWEEN 
TISSUE 
wITHil\J 
ANIMAL 
TOTAL 
AD RE NL 
BRAIN 
LIVER 
PLACEN 
YLK SC 
HEAD 
JAWS 
TORSO 
MEAN 
1823.90 
144.62 
8467.95 
1844.50 
2768.60 
753.05 
1123.90 
730.62 
REJECTED 
7 195036648.87 27862378.42 107.60 
SIGNIFICANT 
(P <. 01) 
20 5178442.24 258922.11 
27 200215091.18 
COMPARISONS OF MEANS K-VALUE 858.13 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
500.02 BRAIN -LIVER 
20.19 LIVER -TORSO 
562.24 LIVER -HEAD 
407.59 LIVER -JAWS 
1685.31 ADRENL-LIVER 
196.64 LIVER -PLACEN 
80.75 LIVER -YLK SC 
76.49 BRAIN -YLK SC 
YLK SC-TORSO 
YLK SC-HEAD 
BRAIN -PLACEN 
AORENL-RRAIN 
YLK SC-JAWS 
PLACEN-TORSO 
ADRENL-TORSO 
PLACEN-HEAD 
ADRENL-HEAD 
BRAIN -JAWS 
ADRENL-YLK SC 
PLACEN-YLK SC 
31 
8323.32 
7737.32 
7714.89 
7344.04 
6644.04 
6623.45 
5699.34 
2623.97 
2037.97 
2015.55 
1699.87 
1679.27 
1644.69 
1113.87 
1093.27 
1091.45 
1070.85 
979.27 
944.70 
924.10 
PLACEN-JAWS 
ADREl'JL-JAWS 
BRAIN -HEAD 
BRAIN -TORSO 
JAWS -TORSO 
HEAD -JAWS 
HEAD -TORSO 
ADRENL-PLACEN 
MEAN 
DIFF. 
720.59 
699.99 
608.42 
586.00 
393.27 
370.85 
22.42 
20.60 
coUNTS 
ANOVA TABLE 3 
1.5 HR 
SOURCE OF 
VARIATION 
DEGREES OF 
FREEDOM 
SUM OF 
SQUARES 
MEAN 
SQUARE F-RATIO 
DECISION 
CONCERNING H0 
BETWEEr~ 
TISSUE 
WITHIN 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PLACEN 
YLK SC 
HEAD 
JAWS 
TORSO 
MEAN 
1334.90 
109.47 
6376.60 
1430.19 
1931.76 
805.37 
885.04 
630.37 
REJECTED 
7 109009044.81 15572720.69 18.53 
23 19328309.22 840361.27 
SIGNIFICANT 
(P <:.01) 
30 128337353.96 
COMPARISONS OF MEANS K-VALUE 1545.98 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
DIFF. STD. COMPARISONS DIFF. COMPARISONS 
588.81 BRAIN -LIVER 
39.85 LIVER -TORSO 
2409.33 LIVER -HEAD 
359.05 LIVER •JAWS 
123.19 ADRENL-LIVER 
239.45 LIVER -PLACEN 
241.03 LIVER •YLK SC 
187.42 BRAIN -YLK SC 
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6267.12 BRAIN •PLACEN1320.72 
5746.22 YLK SC-TORSO 1301.39 
5571.22 ADRENL•BRAIN 1225.42 
5491.54 YLK SC-HEAD 1126.39 
5041.70 YLK SC-JAWS 1046.71 
4946.40 PLACEN-TORSO 799.82 
4444.83 BRAIN •JAWS 775.57 
1822.29 ADRENL-TORSO 704.52 
BRAIN -HEAD 695.90 
PLACEN-HEAD 624.82 
ADRENL"YLK SC 596.86 
PLACEN-JAWS 545.15 
ADRENL-HEAD 529.52 
BRAIN -TORSO 520.90 
PLACEN-YLK SC 501.56 
ADRENL-JAWS 44q.84 
JAWS -TORSO 254.67 
HEAD •TORSO 175.00 
ADRENL-PLACEN 95.30 
HEAD -JAWS 79.67 
coUNTS ANOVA TABLE 4 
2.0 HR 
souRCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
BETWEEN 7 58'+529'+. 08 8350'+2.01 '+7.82 
REJECTED 
TISSUE SIGNIFICANT 
WITHIN 22 38'+112.28 17'+59. 61.f. (P<:'.01) 
ANIMAL 
TOTAL 29 62291f.06.36 
COMPARISONS OF MEANS K-VALUE 222.83 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 229.35 85.1.f.O BRAIN -LIVER 1'+08.57 ADRENL•BRAIN 201.ao 
BRAIN 21.5'+ 5.99 LIVER -TORSO 1276.12 PLACEN-TORSO 203.07 
LIVER 11.f.30.12 176. 7'+ LIVER -JAWS 1271.59 PLACEN-JAWS 198.5'+ 
PLACEN 357.07 63.59 LIVER -HEAD 1257.32 PLACEN-HEAD 18'+.27 
YLK SC 705.79 31f.'+.09 ADRENL•LIVER 1200.77 BRAIN •HEAD 151.25 
HEAD 172.80 '+9 .13 LIVER -PLACEN 1073.05 BRAIN -JAWS 136.98 
JAWS 158.53 27 .'+O LIVER -YLK SC 72'1-.32 BRAIN •TORSO 132. '+5 
TORSO 15'+.00 59.79 BRAIN -YLK SC 684.25 ADRENL-PLACEN 127.72 
YLK SC•TORSO 551.80 ADRF'NL-TORSO 75.35 
YLK SC•JAWS 51.f.7.26 ADRENL•JAWS 70.81 
YLK SC-HEAD 533.00 ADRENL-HEAD 56.55 
ADRENL-YLK SC '+76.'+l.f. HEAD •TORSO 18.79 
PLACEN-YLK SC 31.f.8. 72 HEAD -JAWS 1'+.26 
BRAIN •PLACEN 335.52 JAWS -TORSO '+e53 
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couNTS ANOVA TABLE 5 
3.0 HR 
soURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 7 118'+'+900.08 1692128.58 5.9'+ 
nssuE SIGNIFICANT 
23 6551011.88 28'+826.60 
(P <.Ol) 
WITHIN 
ANIMAL 
TOTAL 30 18395911.96 
COMPARISONS OF MEANS K-VALUE 900.0'+ 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 373.83 203.'+8 BRAIN -PLACEN 159'+.71 YLK SC-JAWS 785.Lf.2 
BRAIN 33.52 22.66 BRAIN -LIVER 15'+6.37 BRAIN -JAWS 577.87 
LIVER 1579.90 Lf.'+3. 75 PLACEN·TORSO 1405.66 JAWS -TORSO 388.82 
PLACEN 1628.2'+ 1206.65 BRAIN •YLK SC 1363.30 ADRENL·BRAIN 31.f.O. 30 
YLK SC 1396.82 117.96 LIVER -TORSO 1357.32 BRAIN •HEAD 319.77 
HEAD 353.29 166.36 PLACEN-HEAD 1271.f..94 HEAD -JAWS 258.10 
JAWS 611.'+0 189.67 ADRENL•PLACEN 1254.40 ADRENL-JAWS 237.56 
TORSO 222.57 73.0'+ LIVER •HEAD 1226.60 PLACEN-YLK SC 231.41 
AORENL•LJVER 1206.06 BRAIN -TORSO 189.05 
YLK SC-TORSO 1174.25 LIVER •YLK SC 183.07 
YLK SC-HEAD 10'+3.52 ADRENL•TORSO 151.25 
AORENL-YLK SC 1022.99 HEAD -TORSO 130.72 
FLACEN-JAWS 1016.83 LIVER -PLACEN 48.33 
LIVER •JAWS 968.50 ADRENL-HEAD 20.53 
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coUNTS ANOVA TABLE 6 
ADRENL 
SOURCE OF 
VARIATION 
DEGREES OF 
FREEDOM 
SUM OF 
SQUARES 
MEAN 
SQUARE F-RATIO 
DECISION 
CONCERNING H0 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
MEAN 
3082.39 
1823.90 
1334.90 
229.35 
373.83 
14 
18 
REJECTED 
20689758.17 5172439.54 13.78 
5253351.45 375239.38 
SIGNIFICANT 
(P <. 01) 
25943109. 64 
COMPARISONS OF MEANS K-VALUE 1208.11 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
MEAN 
DIFF. 
1058.05 .5 HR-2.0 HR 2853.05 1.5 HR-2.0 HR1105.55 
500.02 .5 HR-3.0 HR 2708.56 1.5 HR-3.0 HR 961.06 
588.81 .5 HR-1.5 HR 1747.50 1.0 HR-1.5 HR 489.00 
85.'+0 1.0 HR-2.0 HR 1594.55 2.0 HR-3.0 HR 144.48 
203.48 1.0 HR-3.0 HR 1450.06 
.5 HR-1.0 HR 1258.50 
35 
couNTS ANOVA TABLE 7 
BRAIN 
soURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 4 110305.79 27576.44 49.63 
TIME SIGNIFICANT 
555.60 
(P < .01) 
WITHIN 15 8334.11 
ANIMAL 
TOTAL 19 118639.90 
COMPARISONS OF MEANS K•VALUE 46.06 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 222.99 15.25 .5 HR-2.0 HR 201.44 1.0 HR•l.5 HR 35.15 
1.0 HR 144.62 20.19 .5 HR-3.0 HR 189.47 2.0 HR-3.0 HR 11.97 
1.5 HR 109.47 39.85 1.0 HR-2.0 HR 123.07 
2.0 HR 21.54 5.99 .5 HR-1.5 HR 113.52 
3.0 HR 33.52 22.66 1.0 HR-3.0 HR 111.09 
1.5 HR-2.0 HR 87.92 
.5 HR-1.0 HR 78.37 
1.5 HR-3.0 HR 75.94 
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cour.irs ANOVA TABLE 8 
LIVER 
soURCE OF 
VARIATION 
DEGREES OF 
FREEDOM 
SUM OF 
SQUARES 
MEAN 
SQUARE 
DECISION 
F-RATIO CONCERNING Ho 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
,5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3,0 HR 
MEAN 
13307,25 
8467.95 
6376.60 
1430.12 
1579.90 
4 
14 
18 
REJECTED 
376333663.25 94083415.81 65.80 
SIGNIFICANT 
(P<:.01) 
20016295.62 1429735.40 
396349958.37 
COMPARISONS OF MEANS K•VALUE 2358.20 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
MEAN 
DIFF. 
623.36 .5 HR-2.0 HR11877.12 1.0 HR•l.5 HR2091.35 
562.24 .5 HR-3,0 HR11727.35 2.0 HR-3.0 HR 149.77 
2409.33 1.0 HR-2.0 HR 7037.82 
176.74 .5 HR-1,5 HR 6930.65 
443.75 1.0 HR-3,0 HR 6888.04 
1.5 HR-2,0 HR 4946.47 
.5 HR-1.0 HR 4839.30 
1.5 HR-3.0 HR 4796.70 
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coutJTS ANOVA TABLE 9 
PLACEN 
soURCE OF 
VARIATION 
DEGREES OF 
FREEDOM 
SUM OF 
SQUARES 
MEAN 
SQUARE F .. RATIO 
DECISION 
CONCERNING Ho 
REJECTED 
BETWEEN 
TIME 
wITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
MEAN 
2441.45 
1844.50 
1430.19 
357.07 
1628.24 
4 
16 
20 
9305309.66 2326327.41 5.28 
SIGNIFICANT 
(P <. 01) 
7041701.19 440106.32 
16347010.85 
COMPARISONS OF MEANS K-VALUE 1284.64 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
326.75 .5 HR-2.0 HR 2084.37 2.0 HR-3.0 
407.59 1.0 HR-2.0 HR 1487.42 1.5 HR-2.0 
359.05 .5 HR-1.5 
63.59 .5 HR-3.0 
MEAN 
DIFF. 
HR1271.16 
HR1073.12 
HR1011.25 
HR 813.21 
1206.65 .5 HR-1.0 HR 596.95 
1.0 HR-1.5 HR 414.30 
1.0 HR-3.0 HR 216.26 
1.5 HR-3.0 HR 198.04 
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couNTS 
souRCE OF 
VARIATION 
BETWEErJ 
TIME 
WITHIN 
ANIMAL 
TOTAL 
ANOVA TABLE 10 
YLK SC 
DEGREES OF 
FREEDOM 
SUM OF 
SQUARES 
4 14321905.69 
11 6074720.00 
15 20396625.64 
COMPARISONS OF 
MEAN DECISION 
SQUARE F-RATIO CONCERNING Ho 
REJECTED 
3580476.42 6.48 SIGNIFICANT 
(P °"'· 01) 
552247.27 
MEANS K-VALUE 1518.79 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 3289.25 987.50 .5 HR-2.0 HR 2583.45 1.0 HR-3.0 HR1371.77 
1.0 HR 2768.60 1685.31 1.0 HR-2.0 HR 2062.80 .5 HR-1.5 HR1357.48 
1.5 HR 1931.76 123.19 .5 HR-3.0 HR 1892.42 1.5 HR-2.0 HR1225.96 
2.0 HR 705.79 344.09 1.0 HR-1.5 HR 836.83 
3.0 HH 1396.82 117.96 2.0 HR-3.0 HR 691.02 
1.5 HR•3.0 HR 534.94 
.5 HR-1.0 HR 520.65 
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ANOVA TABLE 11 
HEAD 
soURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 4 2115615.48 528903.87 17.86 
TIME SIGNIFICANT 
(P <. 01) 
WITHIN 14 414555.49 29611.10 
ANIMAL 
TOTAL 18 2530170.97 
COMPARISONS OF MEANS K-VALUE 339.37 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 1143.73 134.63 .5 HR-2.0 HR 970.93 .5 HR-1.5 HR 338.35 
1.0 HR 753.05 196.64 .5 HR-3.0 HR 790.43 2.0 HR-3.0 HR 180.50 
1.5 HR 805.37 239.45 1.5 HR-2.0 HR 632.57 1.0 HR-1.5 HR 52.32 
2.0 HR 172.80 49.13 1.0 HR-2.0 HR 580.25 
3.0 HR 353.29 166.36 1.5 HR-3.0 HR 452.07 
1.0 HR-3.0 HR 399.75 
.5 HR-1.0 HR 390.68 
40 
couNTS ANOVA TABLE 12 
JAWS 
soURCE OF 
VARIATION 
DEGREES OF 
FREEDOM 
SU111! OF 
SQUARES 
MEAN 
SQUARE F-RATIO 
DECISION 
CONCERNING Ho 
REJECTED 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
12 
16 
MEAN 
1364.20 
1123.90 
885.04 
158.53 
611.40 
2869916.81 717479.20 
SIGNIFICANT 
(P <. 01) 
482965.79 40247.14 
3352882.61 
COMPARISONS OF MEANS K-VALUE 404.63 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
253.45 .5 HR-2.0 HR 1205.66 1.5 HR-3.0 
80.75 1.0 HR-2.0 HR 965.36 .5 HR-1.0 
241.03 .5 HR-3.0 HR 752.80 1.0 HR•l.5 
27.40 1.5 HR-2.0 HR 726.51 
189.67 1.0 HR-3.0 HR 512.50 
.5 HR-1.5 HR 479.15 
2.0 HR-3.0 HR 452.86 
41 
HR 
HR 
HR 
MEAN 
DIFF. 
273.64 
240.30 
238.85 
coUi'JTS 
ANOVA TABLE 13 
TORSO 
soURCE OF DEGREES OF SUM OF MEAN DECISION 
VARI.ilTIOl'J FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 4 1615463.03 403865.75 38.65 
TIME SIGNIFICANT 
(P < .01) 
WITHIN 15 156706.75 10447.11 
ANIMAL 
TOTAL 19 1772169.78 
COMPARISONS OF MEANS K-VALUE 199.75 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 873.45 48.43 .5 HR-2.0 HR 719.45 .5 HR-1.0 HR 142.82 
1.0 HR 730.62 76.49 .5 HR-3.0 HR 650.87 1.0 HR-1.5 HR 100.25 
1.5 HR 630.37 187.42 1.0 HR-2.0 HR 576.62 2.0 HR-3.0 HR 68.57 
2.0 HR 154.00 59.79 1.0 HR-3.0 HR 508.04 
3.0 HR 222.57 73.04 1.5 HR-2.0 HR 476.37 
1.5 HR-3.0 HR 407.79 
.5 HR-1.5 HR 243.07 
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cRTSOL 
soURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 14 
HEAD 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING 1-b 
ACCEPTED 
l.f. '+78.73 119.68 1.29 
NONSIGNIFICANT 
(P>.OS) 
15 1381.1+9 92.09 
19 1860.22 
COMPARISONS OF MEANS K•VALUE 18.75 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
38.50 15.20 1.5 HR-3.0 HR 13.87 
'+1.52 l.f..62 2.0 HR•3.0 HR 12.12 
35.67 2.08 .5 HR•3.0 HR 11.05 
37.1.f.2 8.33 1.0 HR-3.0 HR a.02 
'+9.55 11.58 1.0 HR-1.5 HR 5. 84 
1.0 HR-2.0 HR l.f.e09 
.5 HR-1.0 HR 3.02 
.5 HR-1.5 HR 2.a2 
1.5 HR-2.0 HR 1.75 
.5 HR-2.0 HR 1.01 
51 
r 
cRTSOL 
ANOVA TABLE 15 
JAWS 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
ACCEPTED 
BETwEEN 4 56.62 1'+.15 0.11 
TIME NONSIGNIFICANT 
(P >.OS) 
WITHIN 12 1467.88 122.32 
ANIMAL 
TOTAL 16 1524.50 
COMPARISONS OF MEANS K·VALUE 22.30 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
,5 HR 40.12 11.71 .5 HR-1.0 HR 6.37 
1.0 HR 46.50 7.63 1.0 HR-2.0 HR 4.96 
1.5 HR 42.59 5.81 1.0 HR-3.0 HR 3.92 
2.0 HR '+l.53 18.07 l.o HR-1.5 HR 3.90 
3.0 HR '+2.57 9.00 .s HR•l.5 HR 2.1+1 
.5 HR-3.0 HR 2.1+5 
.5 HR•2.0 HR 1.40 
1.5 HR-2.0 HR 1.06 
2.0 HR-3.0 HR 1.04 
1.5 HR-3.0 HR 0.02 
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CRT SOL 
ANOVA TABLE 16 
TORSO 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 109.15 27.28 0.29 
T Il"IE NONSIGNIFICANT 
(P >. 05) 
WITHIN 15 1385.42 92.36 
ANIMAL 
TOTAL 19 1494.57 
COMPARISONS OF MEANS K-VALUE 18.78 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 34.62 7.03 .5 HR•2.0 HR 7.15 
1.0 HR 38.62 4.89 .5 HR-1.5 HR 5.09 
1.5 HR 39.72 1.48 .5 HR-3.0 HR 4.52 
2.0 HR 41.77 7.78 .5 HR-1.0 HR 4.00 
3.0 HR 39.15 18.04 1.0 HR-2.0 HR 3.15 
2.0 HR-3.0 HR 2.62 
1.5 HR-2.0 HR 2.05 
1.0 HR-1.5 HR 1.09 
1.5 HR•3.0 HR o.57 
1.0 HR-3.0 HR o.52 
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soURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
,5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 17 
HEAD 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
4 838.31 209.57 3.15 
SIGNIFICANT 
15 997.69 66.51 (. 05 >P > . 01) 
19 1836.00 
COMPARISONS OF MEANS K-VALUE 15.93 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
31.44 14.53 .5 HR-3.0 HR 18.82 .5 HR-2.0 HR 14.37 
24.29 4.92 1.0 HR-3.0 HR 11.67 
23.72 7.40 1.5 HR•3.0 HR 11.10 
17.07 3.66 .5 HR•l.5 HR 1.12 
12.62 5.35 1.0 HR-2.0 HR 1.22 
.5 HR-1.0 HR 7.14 
1.5 HR-2.0 HR 6.64 
2.0 HR•3.0 HR 4.45 
1.0 HR•l.5 HR o.57 
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cRTSON 
SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1. 0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 18 
JAWS 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
4 1019.40 254.85 10.15 
SIGNIFICANT 
(P<.Ol) 
12 301.14 25.09 
16 1320.54 
COMPARISONS OF MEANS K-VALUE 10.10 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
31.89 8.63 .5 HR-3.0 HR 19.67 .5 HR-1.5 HR 8.32 
19.95 1.90 .s HR-2.0 HR 19.29 1.0 HR-3.0 HR 7.72 
23.57 3.96 .5 HR-1.0 HR 11. 9lf. 1.0 HR .. 2.0 HR 1. 3lf. 
12.60 1.86 1.5 HR-3.0 HR 11.35 1.0 HR-1.5 HR 3.62 
12.22 2.55 1.5 HR-2.0 HR 10.97 2.0 HR .. 3.0 HR o.37 
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cRTSON 
ANOVA TABLE 19 
TORSO 
souRCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN '+ 983.73 2'+5.93 '+ .86 
TIME SIGNIFICANT 
WITHIN 15 758.88 50.59 
(.OS>P ;:. •• Ql) 
ANIMAL 
TOTAL 19 17'+2.61 
COMPARISONS OF MEANS K-VALUE 13.90 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
,5 HR 37.09 12.00 .5 HR-3.0 HR 21.20 1.5 HR-3.0 HR 12.25 
1.0 HR 27,99 6.85 ,5 HR-2.0 HR 1Lf..6Lf. 1.0 HR-3.0 HR 12.09 
1.5 HR 28.15 5,56 .5 HR-1.0 HR 9.10 
2.0 HR 22.'+5 '+.5'+ .5 HR-1.5 HR a.9Lf. 
3.0 HR 15.89 3,19 2.0 HR-3.0 HR (,.55 
1.5 HR-2.0 HR 5.70 
1.0 HR-2.0 HR 5. 5Lf. 
1.0 HR-1.5 HR 0.15 
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ANOVA TABLE 20 
HEAD 
soURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
BETWEDJ 4 242.91 60.72 2.36 
ACCEPTED 
TIME NONSIGNIFICANT 
WITHIN 15 385.25 25.68 
(P >.05) 
ANIMAL 
TOTAL 19 628.16 
COMPARISONS OF MEANS K-VALUE 9.90 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 10.47 3.25 .5 HR-1.0 HR 10.49 .5 HR-3.0 HR 7.94 
1.0 HR 20.97 6.45 .5 HR-1.5 HR 6.20 
1.5 HR 16.67 4.43 1.0 HR-2.0 HR 5.30 
2.0 HR 15.67 1.94 .5 HR-2.0 HR 5.19 
3.0 HR 18.42 7.25 1.0 HR-1.5 HR 4.29 
2.0 HR-3.0 HR 2.75 
1.0 HR-3.0 HR 2.54 
1.5 HR-3.0 HR 1.74 
1.5 HR-2.0 HR 1.00 
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uNDMET 
SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 21 
JAWS 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
4 180.97 45. 24 2. 24 
ACCEPTED 
NONSIGNIFICANT 
12 2'+2.10 20.17 (P >.OS) 
16 423.08 
COMPARISONS OF MEANS K·VALUE 9.05 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS OIFF. COMPARISONS DIFF. 
11.52 1.15 .5 HR-3.0 HR 9.14 1.0 HR-3.0 HR 6.27 
1'+.40 4.80 2.0 HR-3.0 HR 6.00 
16.92 5.91 .5 HR ... 1.5 HR 5.39 
14.66 3.26 1.5 HR ... 3.0 HR 3.75 
20.67 5.43 .5 HR-2.0 HR 3.14 
.5 HR•l.O HR 2.87 
1.0 HR•l.5 HR 2.52 
1.5 HR-2.0 HR 2.25 
1.0 HR-2.0 HR 0.26 
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soURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 22 
TORSO 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
l.j. 256.10 64.02 1.58 
NONSIGNIFICANT 
15 606.15 40.41 (P:>.05) 
19 862.26 
COMPARISONS OF MEANS K-VALUE 12.42 
SIGNIF. RANKED MEAN NON ... SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
13.09 4.65 .5 HR-3.0 HR 10.70 
21.14 6.94 .5 HR .. 1.0 HR a.o5 
18.90 4.97 .5 HR .. 2.0 HR 7.62 
20.72 3.13 .5 HR•le5 HR 5.80 
23.79 9.87 1.5 HR-3.0 HR 4e89 
2.0 HR-3.0 HR 3.07 
1.0 HR-3.0 HR 2.65 
1.0 HR•l.5 HR 2.24 
1.5 HR-2.0 HR 1.a2 
1.0 HR-2.0 HR o.42 
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ANOVA TABLE 23 
HEAD 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 4 231.87 57.96 7.35 
TIME SIGNIFICANT 
(P <. 01) 
WITHIN 15 118.15 7.87 
ANIMAL 
TOTAL 19 350.02 
COMPARISONS OF MEANS K-VALUE 5.48 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 2.95 1.67 1.0 HR-2.0 HR 9.12 1.0 HR•3.0 HR 5.44 
1. 0 HR 2.67 1. 8'+ .5 HR-2.0 HR 8.85 .5 HR-3.0 HR 5.17 
1.5 HR 6.12 0.68 1.5 HR-2.0 HR 5.67 2.0 HR•3.0 HR 3.67 
2.0 HR 11. 80 4.40 1.0 HR-1.5 HR 3.45 
3.0 HR a.12 3.65 .5 HR•l.5 HR 3.17 
1.5 HR-3.0 HR 2.00 
.5 HR-1.0 HR 0.21 
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oRIGil\J 
SOURCE OF 
VARIATION 
BETWEEfJ 
Til"IE 
WITHIN 
ANIMAL 
TOTAL 
,5 HR 
1,0 HR 
1.5 HR 
2,0 HR 
3,0 HR 
ANOVA TABLE 24 
JAWS 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
4 208.26 52.06 2.69 ACCEPTED 
NONSIGNIFICANT 
12 231.91 19,32 (P >.OS) 
16 440.18 
COMPARISONS OF MEANS K•VALUE 8.86 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS OIFF. 
3,00 0.57 .5 HR-3.0 HR 9.17 2.0 HR-3.0 HR a.11 
6,35 5.44 1.5 HR-3.0 HR 6.47 
5.69 1,99 1.0 HR-3.0 HR 5.a2 
3,39 2,95 ,5 HR•l.O HR 3,35 
12.17 7.56 1.0 HR-2.0 HR 2.95 
.5 HR•l.5 HR 2.10 
1.5 HR-2.0 HR 2.30 
1.0 HR-1.5 HR o.65 
.5 HR-2.0 HR o.39 
61 
ORIGIN 
ANOVA TABLE 25 
TORSO 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
ACCEPTED 
BEHJEEN 4 260.43 65.10 2.61 
TIME NONSIGNIFICANT 
WITHIN 15 373.31 24.88 
(P > .05) 
ANIMAL 
TOTAL 19 633.74 
COMPARISONS OF MEANS K-VALUE 9.74 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 3.67 2.10 1.0 HR-3.0 HR 10.45 .5 HR .. 3.0 HR a.a2 
1.0 HR 2.05 0.97 1.5 HR-3.0 HR 7.97 
1.5 HR 4.52 2.38 2.0 HR .. 3.0 HR 6.52 
2.0 HR 5.97 2.27 1.0 HR-2.0 HR 3.92 
3.0 HR 12.50 10.26 1.0 HR•l.5 HR 2.47 
.5 HR ... 2.0 HR 2.30 
.5 HR .. 1.0 HR 1.62 
1.5 HR-2.0 HR 1.45 
.5 HR .. 1.5 HR o.a4 
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A NOVA TABLE 26 
.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F ... RATIO CONCERNING Ho 
BETWEEN 7 3180.15 
REJECTED 454.30 5.86 
TISSUE S IGNTFICANT 
WITHIN 24 1857.96 77.41 
(P <.Ol) 
ANIMAL 
TOTAL 31 5038.11 
COMPARISONS OF MEANS K .. VALUE 14.55 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 36.27 4.39 BRAIN •LIVER 36.25 PLACEN•TORSO 13.87 
BRAIN 53.84 7.54 LIVER ... pLACEN 30.90 BRAIN •JAWS 13.72 
LIVER 17.60 3.41 LIVER •JAWS 22.52 ADRENL .. PLACEN 12.22 
PLACEN 48.50 5.93 LIVER •HEAD 20.90 PLACEN•YLK SC 10.02 
YLK SC 38.47 8.86 LIVER •YLK SC 20.87 PLACEN•HEAD 10.00 
HEAD 38.50 15.20 BRAIN •TORSO 19.22 PLACEN•JAWS a.37 
JAWS 40.12 11.71 ADRENL-LIVER 18.67 JAWS ·TORSO 5.50 
TORSO 34.62 7.03 ADRENL ... BRAIN 17.57 BRAIN •PLACEN 5.34 
LIVER -TORSO 17.02 HEAD .. TORSO 3.87 
BRAIN ·YLK SC 15.37 ADRENL-JAWS 3.94 
BRAIN -HEAD 15.35 YLK sc .. TORSO 3.ai+ 
ADRENL•HEAD 2.22 
ADRENL-YLK SC 2.19 
YLK SC-JAWS 1.65 
ADRENL•TORSO le65 
HEAD •JAWS 1.62 
YLK SC-HEAD 0.02 
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cRTSOL 
ANOVA TABLE 27 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 7 3086.20 Lf.Lf.O .a0 8.26 
TISSUE SIGNIFICANT 
(P < .01) 
WITHIN 20 1066.66 53.33 
ANIMAL 
TOTAL 27 '+152.86 
COMPARISONS OF MEANS K•VALUE 12.31 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
AD RE NL 36.65 9.1.f.9 LIVER •PLACEN 33.75 ADRENL•PLACEN 12.29 
BRAIN '+6.87 11.07 BRAIN •LIVER 31.67 BRAIN •YLK SC 11.Lf.7 
LIVER 15.20 5.89 LIVER -JAWS 31.29 YLK SC-JAWS 11.10 
PLACEN '+8.95 2.1'+ LIVER •HEAD 26.32 PLACEN•TORSO 10.32 
YLK SC 35. '+0 10. 7Lf. LIVER •TORSO 23.'+2 ADRENL•BRAIN 10.22 
HEAD '+l. 52 '+.62 ADRENL-LIVER 21.'+5 A DRE NL-JAWS 9.85 
JAwS '+6.50 7.63 LIVER •YLK SC 20.20 BRAIN •TORSO a.25 
TOK SO 38.62 '+. 89 PLACEN-YLK SC 13. 51.f. JAWS •TORSO 1.a1 
PLACEN-HEAD 7.'+2 
YLK SC-HEAD 6.12 
BRAIN -HEAD 5.31.f. 
HEAD -JAWS c+.97 
ADRENL•HEAD i+.87 
YLK SC-TORSO 3.22 
HEAD -TORSO 2.90 
PLACEN-JAWS 2. '+'+ 
BRAIN •PLACEN 2.01 
ADRENL•TORSO 1.97 
ADRENL-YLK SC 1.25 
BRAIN -JAWS o.37 
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ANOVA TABLE 28 
1.5 HR 
soURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
REJECTED 
BETWEEN 7 3423.18 489.02 7.40 
TISSUE SIGNIFICANT 
(P <. 01) 
WITHIN 23 1519.10 66.04 
ANIMAL 
TOTAL 30 4942.28 
COMPARISONS OF MEANS K•VALUE 13.70 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 49.07 18.27 ADRENL•LIVER 34.40 ADRENL·HEAD 13.39 
BRAIN 47.20 2.88 LIVER -PLACEN 32.60 PLACEN-HEAO 11.60 
LIVER 14.67 4.70 BRAIN -LIVER 32.52 BRAIN •HEAD 11.52 
PLACEN 47.27 2.15 LIVER •JAWS 27.92 ADRENL•TORSO 9.35 
YLK SC 41.83 12.05 LIVER •YLK SC 27.15 PLACEN•TORSO 7.55 
HEAD 35.67 2.08 LIVER -TORSO 25.04 BRAIN •TORSO 7.47 
JAWS 42.59 5.81 LIVER •HEAD 21.00 ADRENL•YLK SC 7.24 
TORSO 39.72 1.48 HEAD •JAWS 6e92 
ADRENL•JAWS 6.47 
YLK SC•HEAD 6.15 
PLACEN ... YLK SC 5.44 
BRAIN •YLK SC 5.36 
PLACEN•JAWS 4.67 
BRAIN •JAWS 4e60 
HEAD •TORSO 4.04 
JAWS •TORSO 2.87 
YLK SC-TORSO 2.10 
ADRENL-BRAIN 1.87 
ADRENL .. PLACEN 1.79 
YLK SC•JAWS o.76 
BRAIN •PLACEN 0.01 
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cRTSOL 
ANOVA TABLE 29 
2.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F·RATIO CONCERNING Ho 
BETWEEN 7 3Lf.09.Lf.5 Lf.87.06 5.51 '.REJECTED 
TISSUE SIGNIFICANT 
WITHIN 22 19Lf.2.79 88.30 (P<.Ol) 
ANIMAL 
TOTAL 29 5352.25 
COMPARISONS OF MEANS K•VALUE 15.8Lf. 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 29.90 12.78 BRAIN -LIVER 3Lf..77 ADRENL-BRAIN 15.67 
BRAil'J Lf.5.57 10.56 LIVER -TORSO 30.97 ADRENL•TORSO 11.87 
LIVER 10.80 3.1'+ LIVER •JAWS 30.73 ADRENL•JAWS 11.63 
PLACEN 39.65 0.'+7 LIVER •YLK SC 30.10 ADRENL•YLK SC 11.00 
YLK SC Lf.0.90 '+.68 LIVER -PLACEN 28.85 ADRENL•PLACEN 9.75 
HEAD 37.'+2 8.33 LIVER -HEAD 26.62 BRAIN •HEAD a.15 
JAWS '+1.53 18.07 ADRENL-LIVER 19.10 ADRENL•HEAD 7.52 
TORSO Lf.1. 77 7.78 BRAIN •PLACEN 5.92 
BRAIN -YLK SC Lf. .67 
HEAD -TORSO Lf.. 3'+ 
HEAD •JAWS Lf. .10 
BRAIN ... JAWS Lf. • OLf. 
BRAIN •TORSO 3.80 
YLK SC•HEAD 3.Lf.7 
PLACEN-HEAD 2.22 
PLACEN•TORSO 2.12 
PLACEN-JAWS 1.88 
PLACEN•YLK SC 1.25 
YLK SC-TORSO o.a1 
YLK SC-JAWS o.63 
JAW~ .. TORSO 0.21+ 
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cRTSOL 
souRCE OF 
VARIATION 
BETWEEN 
TISSUE 
WITHIN 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PL AC EN 
YLK SC 
HEAD 
JAWS 
TORSO 
ANOVA TABLE 30 
3.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
7 2921.40 417. 34 1.68 
NONSIGNIFICANT 
(P >.OS) 
23 5694.51 247.58 
30 8615.92 
COMPARISONS OF MEANS K-VALUE 26.53 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
32.90 27.85 LIVER -HEAD 38.81 LIVER •YLK SC 25.19 
37.84 17.15 LIVER -JAWS 31.84 LIVER •PLACEN 23.38 
10.73 1.42 LIVER •TORSO 28.L+1 ADRENL·LIVER 22.16 
34.12 15.96 BRAIN ·LIVER 27.11 ADRENL•HEAD 16.65 
35.92 14.30 PLACEN·HEAD 15.1.f.3 
Lf.9. 55 11.58 YLK SC-HEAD 13.62 
42.57 9.oo BRAIN .. HEAD 11.10 
39.15 18.04 HEAD -TORSO 10.L+O 
AORENL•JAWS 9.67 
PLACEN•JAWS 8.1.f.5 
HEAD •JAWS 6.97 
YLK SC-JAWS 6.65 
ADRENL•TORSO 6e25 
PLACEN•TORSO 5.03 
ADRENL•BRAIN 4.94 
BRAIN -JAWS 4.12 
BRAIN •PLACEN 3.72 
JAWS ·TORSO 3.42 
YLK SC-TORSO 3.22 
ADRENL•YLK SC 3.02 
BRAIN -YLK SC 1.92 
PLACEN-YLK SC 1.80 
BRAIN •TORSO 1.30 
ADRENL-PLACEN 1.22 
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r cRTSON 
A NOVA TABLE 31 
.5 HR 
50URCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 7 4614.53 659.21 10.39 
TISSUE SIGNIFICANT 
WITHIN 24 1522.53 63.43 
(P < .01) 
ANIMAL 
TOTAL 31 6137.07 
COMPARISONS OF MEANS K-VALUE 13.17 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 11.92 5.20 LIVER •TORSO 35.12 BRAIN •PLACEN 11.'f.2 
BRAIN 10.47 2.aa LIVER -YLK SC 30.22 PLACEN ... YLK SC 10.29 
LIVER 1.97 o.2a LIVER -JAWS 29.92 PLACEN•JAWS 9.99 
PLACEN 21.90 4.'f.5 LIVER -HEAD 29.47 ADRENL•PLACEN 9.97 
YLK SC 32.20 '+.69 BRAIN -TORSO 26.62 ADRENL-LIVER 9.95 
HEAD 31.4'+ 14.53 ADRENL-TORSO 25.17 PLACEN-HEAD 9.54 
JAWS 31.89 8.63 BRAIN •YLK SC 21.72 BRAIN •LIVER a.so 
TORSO 37.09 12.00 BRAIN -JAWS 21.1.1-2 HEAD •TORSO 5.65 
BRAIN -HEAD 20.97 JAWS ·TORSO 5.19 
ADRENL-YLK SC 20.27 YLK SC-TORSO 4.90 
A DRE NL-JAWS 19.97 ADRENL•BRAIN 1.'f.4 
LIVER -PLACEN 19.92 YLK SC-HEAD o.75 
ADRENL•HEAD 19.52 HEAD -JAWS o.45 
PL AC EN-TORSO 15.19 YLK sc .. JAWS 0.29 
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. soURCE OF 
VARIATION 
BETWEEN 
TISSUE.. 
wITHif\l 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PLACEN 
YLK SC 
HEAD 
JAWS 
TORSO 
ANOVA TABLE 32 
1.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
7 2162.52 308.93 12.90 
SIGNIFICANT 
(P <::. 01) 
20 478.87 23.94 
27 2641.40 
COMPARISONS OF MEANS K ... VALUE 8.25 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
8.17 3.06 LIVER -TORSO 24.12 PLACEN-YLK SC a.12 
8.35 8.34 LIVER -YLK SC 22.12 JAWS -TORSO 8.04 
3.87 0.89 LIVER -HEAD 20.42 PLACEN-HEAD 6.1+2 
17.87 2.67 ADRENL-TORSO 19.82 YLK SC-JAWS 6.05 
26.00 0.10 BRAIN -TORSO 19.64 BRAIN -LIVER 4.47 
24.29 4.92 ADRENL- YLK SC 17.82 HEAD -JAWS 4.34 
19.95 1.90 BRAIN -YLK SC 17.65 AORENL-LIVER 4.30 
27.99 6.85 ADRENL-HEAD 16.12 HEAD -TORSO 3.69 
LIVER -JAWS 16.07 PLACEN•JAWS 2.01 
BRAIN -HEAD 15.94 YLK SC-TORSO 1.99 
LIVER -PLACEN 14.00 YLK SC-HEAD 1.10 
ADRENL-JAWS 11.77 ADRENL•BRAIN 0.11 
BRAIN -JAWS 11.60 
PLACEN-TORSO 10.12 
ADRENL-PLACEN 9.70 
BRAIN -PLACEN 9.52 
69 
cRTSON 
ANOVA TABLE 33 
1.5 HR 
soURCE OF DEGREES OF SUM OF MEAN DECISION 
VAR I AT I ON FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
BETWEEN 7 2002.20 286.02 10.85 
REJECTED 
TISSUE SIGNIFICANT 
WITHIN 23 605.97 26.3'+ 
(P <'. 01) 
ANIMAL 
TOTAL 30 2608.18 
COMPARISONS OF MEANS K-VALUE 8.65 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADREl\JL 11.3'+ 6.31 LIVER 00 TORSO 2'+.67 BRAIN •LIVER 0.55 
BRAIN 12.02 5.61 LIVER -YLK SC 22.05 PLACEN-YLK SC a.o3 
LIVER 3.'+7 1.78 LIVER •HEAD 20.25 ADRENL•LIVER 7.87 
PLACEN 17.50 '+. '+8 LIVER -JAWS 20.10 PLACEN-HEAD 6.22 
YLK SC 25.53 2.92 ADRENL-TORSO 16.80 ADRENL-PLACEN 6el5 
HEAD 23.72 7.'+0 BRAIN -TORSO 16.12 PLACEN•JAWS 6.07 
JAWS 23.57 3.96 ADRENL-YLK SC 14.18 BRAIN .. PLACEN 5.'+7 
TORSO 28.15 5.56 LIVER -PLACEN 1'+.02 JAWS -TORSO .... 57 
BRAIN -YLK SC 13.50 HEAD .. TORSO 4.q.2 
ADRENL•HEAD 12.37 YLK SC-TORSO 2.61 
ADRENL-JAWS 12.22 YLK SC-JAWS 1.95 
BRAIN •HEAD 11.69 YLK SC-HEAD 1.00 
BRAIN -JAWS 11.55 ADRENL•BRAIN o.67 
PLACEN-TORSO 10.65 HEAD .. JAWS 0.11+ 
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SOURCE OF 
VARIATION 
BETWEEN 
TISSUE 
WITHIN 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PL AC EN 
YLK SC 
HEAD 
JAWS 
TORSO 
ANOVA TABLE 34 
2.0 HR 
MEAN DEGREES OF 
FREEDOM 
SUM OF 
SQUARES SQUARE F-RATIO 
DECISION 
CONCERNING H0 
REJECTED 
7 1249.11 178.44 22.76 
SIGNIFICANT 
22 172.46 7.83 
(P <:. 01) 
29 1421.58 
COMPARISONS OF MEANS K-VALUE 4. 72 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
5. 44 2.11 LIVER -TORSO 19.35 YLK SC-TORSO 4.58 
7.22 2.05 ADRENL-TORSO 11.00 HEAD •JAWS 4.q.7 
3.09 0.6Lf. BRAIN •TORSO 15.22 BRAIN •LIVER 4.12 
ltf..72 2.40 LIVER -YLK SC ltf..76 PLACEN•YLK SC 3.1q. 
17.86 2.10 LIVER •HEAD 13.97 PLACEN•HEAD 2.35 
17.07 3.66 ADRENL-YLK SC 12. 41 ADRENL•LIVER 2.34 
12.60 1.86 ADRENL-HEAD 11.62 PLACEN-JAWS 2.12 
22.45 4.54 LIVER •PLACEN 11.62 ADRENL•BRAIN 1.11 
BRAIN ·YLK SC 10.64 YLK SC-HEAD 0.19 
BRAIN -HEAD 9.85 
JAWS -TORSO 9.85 
LIVER •JAWS 9.50 
ADRENL-PLACEN 9.27 
PLACEN-TORSO 1.12 
BRAIN -PLACEN 7.49 
ADRENL ... JAWS 7.15 
HEAD -TORSO 5.37 
BRAIN -JAWS 5.37 
YLK SC-JAWS 5.26 
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SOURCE OF 
VARIATION 
BETWEEN 
TISSUE 
WITHIN 
ANIMAL 
TOTAL 
AD RE NL 
BRAIN 
LIVER 
PLACEN 
YLK SC 
HEAD 
JAWS 
TORSO 
ANOVA TABLE 35 
3.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
7 561.10 80.15 1.69 
NONSIGNIFICANT 
(P>.os) 
23 1085.30 Lf.7.18 
30 16Lf.6.Lf.O 
COMPARISONS OF MEANS K-VALUE 11.58 
SIGNIF. RANKED 
MEAN STD. COMPARISONS 
16.89 
5.92 
q.. 33 
10.17 
16.65 
12.62 
12.22 
15.89 
20.80 ADRENL-LIVER 
1.5tf. LIVER -YLK SC 
0.72 
3.77 
2. Lf.tf. 
5.35 
2.55 
3.19 
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MEAN 
DIFF. 
12.56 
12.31 
NON-SIGNIF. MEAN 
COMPARISONS DIFF. 
LIVER ·TORSO 11.56 
ADRENL-BRAIN 10.97 
BRAIN •YLK SC 10.12 
BRAIN •TORSO 9.97 
LIVER -HEAD 8.29 
LIVER -JAWS 7.89 
ADRENL•PLACEN 6.72 
BRAIN -HEAD 6.69 
PLACEN-YLK SC 6.Lf.7 
BRAIN -JAWS 6.30 
LIVER .. pLACEN 5.att-
PLACEN-TORSO 5.72 
ADRENL .. JAWS tf..67 
YLK SC-JAWS 4. tf.2 
ADRENL-HEAD '+•27 
BRAIN -PLACEN q..25 
YLK SC-HEAD tf.. 02 
JAWS -TORSO 3.67 
HEAD -TORSO 3.27 
PLACEN-HEAD 2. tf.4 
PLACEN-JAWS 2 • Otf. 
BRAIN ·LIVER 1.59 
ADRENL ... TORSO o.99 
YLK SC-TORSO o.75 
HEAD -JAWS o.39 
ADRENL-YLK SC 0 .2tf. 
UNDMET 
A NOVA TABLE 36 
.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
BETWEEN 7 2531.f..31 362.0'+ 15.76 
REJECTED 
TISSUE SIGNIFICANT 
WITHIN 2'+ 551.12 22.96 
(P <.Ol) 
ANIMAL 
TOTAL 31 3085.'+3 
COMPARISONS OF MEANS K-VALUE 7.92 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
AD RE NL 20.25 '+.88 LIVER -HEAD 28.87 BRAIN •JAWS 7.89 
BRAIN 19.'+2 a.10 LIVER -JAWS 27.82 BRAIN ... YLK SC 1.a1 
LIVER 39.3'+ 6.70 LIVER -YLK SC 27.79 ADRENL·TORSO 7.15 
PLACEN 15.22 3.12 LIVER -TORSO 26.25 BRAIN •TORSO 6.32 
YLK SC 11.55 2. '+'+ LIVER -PLACEN 21.f..12 ADRENL•PLACEN 5.02 
HEAD 10.'+7 3.25 BRAIN -LIVER 19.92 PLACEN·HEAD i+.75 
JAWS 11.52 1.15 ADRENL-LIVER 19.10 BRAIN •PLACEN 4.19 
TORSO 13.09 '+.65 ADRENL-HEAD 9.77 PLACEN-JAWS 3.70 
BRAIN -HEAD 8.91.f. PLACEN•YLK SC 3.67 
ADRENL-JAWS a.12 HEAD •TORSO 2.62 
ADRENL-YLK SC 8.70 PLACEN-TORSO 2.12 
JAWS ·TORSO 1.57 
YLK SC-TORSO 1.5'+ 
YLK SC-HEAD 1.01 
HEAD -JAWS 1.01+ 
ADRENL·BRAIN 0.82 
YLK SC-JAWS 0.02 
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soURCE OF 
VARIATION 
BETWEEN 
TISSUE 
WITHIN 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PLACEN 
YLK SC 
HEAD 
JAWS 
TORSO 
ANOVA TABLE 37 
1.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
18.27 
19.52 
46.34 
23.89 
16.85 
20.97 
14.40 
21.14 
7 
20 
27 
2562.22 366.03 6.72 REJECTED 
SIGNIFICANT 
1089.02 54.45 (P<.Ol) 
3651.25 
COMPARISONS OF MEANS K-VALUE 12.44 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
STD. COMPARISONS DIFF. COMPARISONS DIFF. 
7.35 LIVER -JAWS 31.95 PLACEN•JAWS 9.49 
9.81 LIVER •YLK SC 29.49 PLAr:EN-YLK SC 1.01+ 
9.13 ADRENL-LIVER 28.07 JAWS •TORSO 6e7tf. 
2.79 BRAIN -LIVER 26.82 HEAD -JAWS 6e57 
8.tf.1 LIVER -HEAD 25.37 ADRENL•PLACEN 5.62 
6.tf.5 LIVER •TORSO 25.20 BRAIN -JAWS 5.12 
4.80 LIVER -PLACEN 22.45 BRAIN •PLACEN 4.37 
6.94 YLK SC-TORSO q..29 
YLK SC-HEAD q..12 
ADRENL•JAWS 3.8? 
PLACEN-HEAD 2.92 
ADRENL-TORSO 2.e1 
PLACEN•TORSO 2.75 
ADRENL-HEAD 2.69 
BRAIN -YLK SC 2.6t 
YLK SC-JAWS 2.4!5 
BRAIN •TORSO 1.62 
BRAIN -HEAD 1.45 
ADRENL•YLK SC 1.42 
ADRENL-BRAIN 1.2q. 
HEAD -TORSO 0.11 
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uNDMET 
ANOVA TABLE 38 
1.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
BETWEEN 7 1177.72 168.24 7.37 REJECTED 
TISSUE SIGNIFICANT 
WITHIN 23 525.01 22.82 (P <.01) 
ANIMAL 
TOTAL 30 1702.73 
COMPARISONS OF MEANS K-VALUE 8.05 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
AD RE NL 13.14 3.82 ADRENL-LIVER 19.79 BRAIN ·LIVER 1.01 
BRAIN 25.87 2.04 LIVER -YLK SC 18.38 BRAIN •TORSO 6.97 
LIVER 32.95 1.01 LIVER ·HEAD 16.27 PLACEN•YLK SC 6.78 
PLACEN 21.35 4.92 LIVER -JAWS 16.02 ADRENL-TORSO 5.75 
YLK SC 14.56 1.88 LIVER ·TORSO 14.01.f. PLACEN-HEAD 4.67 
HEAD 16.67 4.43 ADRENL-BRAIN 12.72 BRAIN •PLACEN 4.52 
JAWS 16.92 5.91 LIVER -PLACEN 11.59 PLACEN-JAWS 4.42 
TORSO 18.90 4.97 BRAIN -YLK SC 11.30 YLK SC-TORSO q..33 
BRAIN •HEAD 9.19 ADRENL-JAWS 3.77 
BRAIN -JAWS 8.95 ADRENL-HEAD 3.52 
ADRENL-PLACEN 8.20 PLACEN•TORSO 2.1+5 
YLK SC-JAWS 2.35 
HEAD -TORSO 2.22 
YLK SC-HEAD 2.10 
JAWS •TORSO 1.97 
ADRENL-YLK SC 1.41 
HEAD -JAWS 0.2'+ 
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UNDMET 
SOURCE OF 
VARIATION 
BETWEEN 
TISSUE 
~JI THIN 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PLACEN 
YLK SC 
HEAD 
JAWS 
TORSO 
ANOVA TABLE 39 
2.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
7 889.90 127.12 7.20 
SIGNIFICANT 
(P <. 01) 
22 387.99 17.63 
29 1277.89 
COMPARISONS OF MEANS K-VALUE 1.08 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
18.25 7.2'+ LIVER -JAWS 18.33 PLACEN-HEAO 6.87 
2'+.35 3.9'+ LIVER -HEAD 17.32 ADRENL•BRAIN 6.10 
33.00 '+. 6'+ ADRENL-LIVER 1'+.75 JAWS •TORSO 6.05 
22.5'+ '+.15 LIVER -YLK SC 12.60 YLK SC-JAWS 5.73 
20.'+0 1.66 LIVER -TORSO 12.27 HEAD ·TORSO 5.05 
15.67 1.9'+ LIVER •PLACEN 10.'+'+ YLK SC-HEAD '+•72 
11.j. .66 3.26 BRAIN ·JAWS 9.68 ADRENL•PLACEN '+•30 
20.72 3.13 BRAIN -HEAD 8.67 BRAIN •YLK SC 3.95 
BRAIN -LIVER 8.61.j. BRAIN •TORSO 3e62 
PLACEN-JAWS 7.88 ADRENL•JAWS 3.58 
ADRENL·HEAD 2.57 
ADRENL-TORSO 2.1+1 
ADRENL•YLK SC 2.15 
PLACEN·YLK SC 2.14 
PLACEN•TORSO 1.a2 
BRAIN •PLACEN 1.ao 
HEAD •JAWS 1.00 
YLK SC-TORSO 0.32 
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ANOVA TABLE 40 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 7 701.58 100.22 2.37 
TISSUE NONSIGNIFICANT 
WITHIN 23 969.05 1+2.13 
(P>.05) 
ANIMAL 
TOTAL 30 1670.63 
COMPARISONS OF MEANS K•VALUE 10.91+ 
SIGNIF, RANKED MEAN NON .. SIGNIF. MEAN 
MEAN STD. COMPARISONS OIFF. COMPARISONS DIFF. 
AORENL 23.03 6.99 LIVER -HEAD 16.60 PLACEN•JAWS 9.36 
BRAIN 23,82 i+.98 LIVER •JAWS 11+.35 ADRENL•PLACEN 7.00 
LIVER 35.03 6.42 AORENL-LIVER 11199 PLACEN ... TORSO 6· 2'f. 
PL AC EN 30. OLf. Lf..48 PLACEN-HEAD 11.61 BRAIN •PLACEN 6121 
YLK SC 2Lf.. 02 5160 LIVER •TORSO 11.23 PLACEN•YLK SC 6101 
HEAD 18.42 7.25 BRAIN -LIVER 11.20 YLK SC-HEAD 5.60 
JAWS 20.67 5. Lf.3 LIVER •YLK SC 11.00 BRAIN -HEAD 5. Lf.0 
TORSO 23.79 9,87 HEAD -TORSO 5.37 
LIVER •PLACEN "'.99 
ADRENL .. HEAD Lf.,60 
YLK SC-JAWS 3,35 
BRAIN -JAWS 3.15 
JAWS -TORSO 3.12 
ADRENL ... JAWS 2.35 
HEAD -JAWS 2.25 
ADRENL•YLK SC o.99 
ADRENL-BRAIN o.79 
ADRENL•TORSO o.76 
YLK SC-TORSO 0.22 
BRAIN •YLK SC 0.20 
BRAIN •TORSO 0.02 
77 
ORIGIN 
SOURCE OF 
VARIATION 
BETWEEN 
TISSUE 
WITHIN 
ANIMAL 
TOTAL 
ADRENL 
BRAIN 
LIVER 
PL AC EN 
YLK SC 
HEAD 
JAWS 
TORSO 
A NOVA TABLE 41 
.5 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
7 4125.27 589.32 33.64 
SIGNIFICANT 
24 420.33 17.51 
(P<.Ol) 
31 4545.61 
COMPARISONS OF MEANS K-VALUE 6.92 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
17.95 9.87 LIVER -HEAD 34.62 PLACEN•HEAD 3.27 
4.67 0.93 LIVER -JAWS 34.57 PLACEN•JAWS 3.22 
37.57 4.69 LIVER •TORSO 33.90 PLACEN•TORSO 2.55 
6.22 1.53 BRAIN ·LIVER 32.90 YLK SC•HEAD 1.90 
4.85 2.62 LIVER -YLK SC 32.72 YLK SC-JAWS 1.as 
2.95 1.67 LIVER -PLACEN 31.35 BRAIN -HEAD 1.12 
3.oo o.57 ADRENL-LIVER 19.62 BRAIN •JAWS 1.67 
3.67 2.70 A DRE NL-HEAD 15.00 BRAIN •PLACEN 1.55 
ADRENL·JAWS 14.95 PLACEN•YLK SC 1.37 
ADRENL-TORSO 14.27 YLK SC-TORSO 1.11 
ADRENL·BRAIN 13.27 BRAIN •TORSO 1.00 
ADRENL-YLK SC 13.10 HEAD •TORSO 0.12 
ADRENL-PLACEN 11.72 JAWS -TORSO o.67 
BRAIN •YLK SC 0.11 
HEAD -JAWS o.os 
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ANOVA TABLE 42 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BEH~EEN 7 2495.67 356.52 8.55. 
TISSUE SIGNIFICANT 
WITHIN 20 833.18 41.65 
(P <.Ol) 
ANIMAL 
TOTAL 27 3328.85 
COMPARISONS OF MEANS K•VALUE 10.aa 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 7.77 8.11 LIVER -TORSO 27.85 BRAIN -JAWS 9.87 
BRAIN 16.22 1.46 LIVER -HEAD 27.22 ADRENL .. BRAIN 8.44 
LIVER 29.89 13.91 LIVER -YLK SC 27.00 ADRENL•TORSO 5.72 
PLACEN 3.95 1.33 LIVER -PLACEN 25.95 ADRENL·HEAD 5.10 
YLK SC 2.90 o.oo LIVER -JAWS 23.54 ADRENL·YLK SC 4.87 
HEAD 2.67 1.84 ADRENL-LIVER 22.12 JAWS •TORSO 4.30 
JAWS 6.35 5.44 BRAIN -TORSO 14.17 ADRENL•PLACEN 3.82 
TORSO 2.05 0.97 BRAIN •LIVER 13.67 HEAD •JAWS 3.67 
BRAIN -HEAD 13.54 YLK SC•JAWS 3.45 
BRAIN ·YLK SC 13.32 PLACEN-JAWS 2.40 
BRAIN -PLACEN 12.27 PLACEN•TORSO 1.90 
ADRENL-JAWS 1.42 
PLACEN-HEAD 1.21 
PLACEN-YLK SC 1.05 
YLK SC-TORSO o.a5 
HEAD 00 TORSO 0.62 
YLK SC-HEAD 0.22 
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ANOVA TABLE 43 
1.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F ... RATIO CONCERNING Ho 
REJECTED 
BETWEEN 7 4755.46 679.35 22.47 
TISSUE SIGNIFICANT 
(P <. 01) 
WITHIN 23 695.12 30.22 
ANIMAL 
TOTAL 30 5450.59 
COMPARISONS OF MEANS K•VALUE 9.27 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 9.80 11.59 LIVER -TORSO 39.67 YLK sc ... TORSO 5.10 
BRAIN 10.10 1.17 LIVER -JAWS 38.50 BRAIN ... TORSO 5.57 
LIVER 44.20 5.46 LIVER -HEAD 38.07 ADRENL•TORSO 5.21 
PLACEN 8.42 4.27 LIVER -PLACEN 35.77 YLK SC-JAWS 4.53 
YLK SC 10.23 7.50 ADRENL-LIVER 34.40 BRAIN -JAWS 4.40 
HEAD 6.12 0.68 BRAIN -LIVER 34.09 YLK SC-HEAD 4.10 
JAWS 5.69 1.99 LIVER ... yLK SC 33.96 ADRENL ... JAWS 4.10 
TORSO 4.52 2.38 BRAIN -HEAD 3.97 
PLACEN-TORSO 3.90 
ADRENL ... HEAD 3.67 
PLACEN-JAWS 2.12 
PLACEN-HEAD 2.29 
PLACEN•YLK SC 1.80 
BRAIN •PLACEN 1.67 
HEAD ·TORSO 1.60 
ADRENL•PLACEN 1.37 
JAWS •TORSO 1.17 
ADRENL-YLK SC o.43 
HEAD •JAWS 0.42 
ADRENL•BRAIN 0.29 
BRAIN •YLK SC 0.13 
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ANOVA TABLE 44 
2.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F·RATIO CONCERNING Ho 
BETWEEN 7 6158.73 879.81 10.23 ~.JECTED 
TISSUE SIGNIFICANT 
WITHIN 22 1890.25 85.92 (P<.Ol) 
ANIMAL 
TOTAL 29 8048.98 
COMPARISONS OF MEANS K•VALUE 15.63 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
ADRENL 32.54 20.52 LIVER •JAWS 4'+.l.f.7 ADRENL·LIVER 15.32 
BRAIN 8.75 9.29 LIVER .. TORSO '+1.90 PLACEN•JAWS 13.25 
LIVER l.f.7 .87 7 .l.f.4 BRAIN .. LIVER 39.12 YLK SC-JAWS 11.76 
PLACEN 16.65 5.1.f.6 LIVER •HEAD 36.07 PLACEN·TORSO 10.67 
YLK SC 15.16 3.13 LIVER •YLK SC 32.70 YLK SC .. TORSO 9.19 
HEAD 11.80 '+. 40 LIVER •PLACEN 31.22 HEAD •JAWS a.i+o 
JAWS 3.39 2.95 ADRENL•JAWS 29.11.f. BRAIN •PLACEN 7.90 
TORSO 5.97 2.27 ADRENL•TORSO 26.57 BRAIN •YLK SC 6.1.f.1 
ADRENL-BRAIN 23.79 HEAD •TORSO 5.82 
ADRENL-HEAD 20.74 BRAIN •JAWS 5.35 
ADRENL-YLK SC 17.38 PLACEN-HEAD 4.84 
ADRENL-PLACEN 15.89 YLK SC•HEAD 3.36 
BRAIN -HEAD 3.05 
BRAIN .. TORSO 2.77 
JAWS •TORSO 2.57 
PLACEN•YLK SC 1.48 
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ORIGIN 
ANOVA TABLE 45 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
BETWEEN 7 2864.60 409.22 3.73 REJECTED 
TISSUE SIGNIFICANT 
WITHIN 23 2521.81 109.64 (P <. 01) 
ANIMAL 
TOTAL 30 5386.41 
COMPARISONS OF MEANS K-VALUE 17.65 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
AD RE NL 17.93 12.28 LIVER •HEAD 36.70 PLACEN•HEAD 13.05 
BRAIN 18.47 9.62 LIVER -JAWS 32.65 BRAIN •HEAD 10.35 
LIVER 44.83 4.10 LIVER -TORSO 32.33 ADRENL•HEAD 9.ao 
PL AC EN 21.17 17.12 LIVER •YLK SC 28.25 PLACEN-JAWS 9.00 
YLK SC 16.57 8.31 AORENL•LIVER 26.90 PLACEN-TORSO 8.67 
HEAD a.12 3.65 BRAIN •LIVER 26.35 YLK SC-HEAD 8.44 
JAWS 12.17 7.56 LIVER -PLACEN 23.65 BRAIN •JAWS 6.30 
TORSO 12.50 10.26 BRAIN •TORSO 5.97 
ADRENL .. JAWS 5.75 
AORENL .. TORSO 5.43 
PLACEN•YLK SC 4.60 
YLK SC-JAWS 4.39 
HEAD -TORSO 4.37 
YLK SC-TORSO 4.07 
HEAD -JAWS 4.os 
ADRENL-PLACEN 3.24 
BRAIN •PLACEN 2.10 
BRAIN •YLK SC 1.90 
ADRENL•YLK SC 1.35 
ADRENL-BRAIN o.54 
JAWS •TORSO 0.32 
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CHAPTER 5 
DISCUSSION 
A. Tri-Carb Oxidizer, Liquid Scintillation Counter, and Thin-layer 
Chromatography 
The Tri-Carb Oxidizer used in conjunction with the Liquid 
Scintillation Counter provided an easy and accurate method of 
measuring the amount of tritium activity in Series A and B 
samples. Oxidizing the samples prior to liquid scintillation 
counting effectively eliminates the problems of color quenching, 
oxygen quenching, chemoluminescene, and solubility factors 
which are inherent in sample preparation methods used in other 
studies. The tritium recovery by oxidative combustion is 
about 97% (Rapkin and Reich, 1971). 
The use of silica gel sheets rather than silica gel layers 
on glass plates, provided an effective and easy method of removing 
the desired thin-layer chromatographic zones. Several pilot 
studies were conducted to determine which solvent would best 
move the known standards while completely separating them from 
each other and the origin. Chloroform/glacial acetic acid/dis-
tilled water (90:10:1) was finally selected as recommended by 
Stahl (1962 and 1969). This provided for a large zone between 
the origin and cortisol to be occupied by the metabolites more 
polar than cortisol. The metabolites in this zone, undetermined 
metabolites, are a group of unconjugated cortisol metabolites, 
of which tetrahydrocortisol, tetrahydrocortisone, cortols, and 
cortones are a few examples (Stahl, 1969). 
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The silica gel samples that were oxidized in the Tri-Carb 
Oxidizer left a silica ash remnant. This remnant was then 
pulverized and counted for radioactivity in the liquid scintilla-
tion counter. This ash was found to be absent of radioactivity. 
B. Extraction of Corticoids from the Maternal and Fetal Tissues 
Acetone has been shown to be an effective method of extracting 
corticosteroids from tissue samples (Bush, 1961). However, the 
finding that not all of the radioactivity was extracted in this 
study is a point that deserved some discussion. 
The per cent of label not in the extract could represent 
the sum of several possible factors. If the tissue cells were 
incompletely homogenized, then the intracellular corticoids could 
not be extracted. Also, the glassware and the filter paper 
probably adsorb some of the extract. 
Another possible source of extraction inefficiency, could 
be protein binding of the corticoids by the cellular components. 
Sekeris et al, (1965) reported that cortisone administered in 
vivo was firmly bound to nuclear proteins (not DNA or RNA) and 
could not be removed by methanol washings. Though a similar 
feature of acetone, to the author's knowledge has not been 
reported, the possibility can not be ruled out. 
C. Sources of Possible Error in the Techniques Used 
From the data reported in DPM/mg. (ANOVA Tables 1 through 13), 
r 85 
it was observed that the standard deviations were as high as 
30% to 50% of the means in some cases. This can be accounted for 
by three main factors. 
First, errors in weighing the tissues were observed in pilot 
studies. Since all tissues can not be weighed immediately and 
simultaneously after dissection, they are subject to differences 
in drying. This error could be added to by inaccuracy of the 
balance. 
Secondly, it was observed in pilot studies that withdrawal 
of exactly 50 uCi (.00042 mg. of cortisol) of stock solution 
was subject to at least 5% error or 2.5 uCi (5.5 x 106 DPM). 
This error, even when differentially distributed over the weight 
of the total mouse (20-23 mg.) and reported in DPM/mg., could 
be significant. The testing an equal volume of the injected 
3H-cortisol for exact radioactive content was precluded by the 
expense. 
Thirdly, errors could result from tissue variability or a 
small sample number, the latter being the most likely. For 
further studies, it is recommended that a larger sample size be 
utilized even at the cost of reducing the number of time intervals. 
Since a 5% error in the 3H-cortisol is only a differential of 
about .000021 mg. cortisol, this amount is quite low considering 
the 10 mg. cortisone acetate in the total dosage injected. It 
could be reasoned that this error of such a low magnitude would 
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have a negligible effect on the metabolism of the 20-23 mg. mouse. 
For the above reasons, the chromatographic data was reported 
in per cents of the total CPM found on the chromatograph for 
that tissue extract only. In this way, possible errors in the 
weight of the tissue and differences in uCi injected would not 
influence the results. The small standard deviation relative to 
the mean for this data (ANOVA Tables 14 through 45) lends 
credence to this reasoning. 
D. The Distribution of Tritium and Tritiated Corticoids in the Maternal 
and Fetal Tissues 
Any discussion concerning the uptake and distribution of an 
injected substance into a pregnant animal, must be superimposed on 
the bases of physiologic compartments and their interaction through 
the connecting blood vascular system. These compartments at the 
macroscopic level include the maternal organs, placenta, extra-
embryonic membranes and the fetuses. 
From Figure 1, the differences in these compartments is 
obvious as far as the distribution of total label is concerned. 
The finding that the maternal liver showed the highest uptake can 
be explained on the basis that 70% of cortisol metabolism occurs 
within this organ. The lowest amount of total label was observed 
in the maternal brain. This can be explained on the basis that 
there is not a free exchange between the brain and the blood. 
This finding corroborates the results reported by Hanngren et al 
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who observed 14c-corticoids to be localized within the ventricles. 
However, the pituitary gland does monitor the level of plasma 
corticoids as feedback for the production and release of ACTH. 
The significantly higher uptake of total label by the yolk 
sac as compared to the placenta at the 1.0 and 2.0 hour interval 
might lend support to the Waddell 1 s (1971) hypothesis that the 
yolk sac carries on metabolic activities. However, from the 
chromatographic data, at all time intervals all per cents of 
labeled corticoids within the yolk sac were not significantly 
different from those in the placenta. This means that the 
differences in total label between the yolk sac and placenta 
are probably compartmental differences in membrane transport 
and tissue absorption as suggested by Snell et al (1956). The 
possibility of metabolism in the yolk sac and/or the placenta 
can not be ruled out without further study. 
Several investigators (Hanngren et al, 1964, Nasjleti et al, 
1967, and Beitens et al, 1970), have similarly reported that 
the fetal tissues showed a significantly lower uptake of total 
label than the maternal tissues (except the brain). From this they 
concluded that the placenta acts as a barrier to the transport 
of corticoids to the embryos. If the yolk sac had not been 
included in this study, a similar conclusion might be drawn. 
However, because the yolk sac demonstrated a more quantitative 
uptake of total label than the placenta, the theory of a "pla-
cental barrier" can be seriously questioned. 
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It has been shown that the embryonic circulatory system 
includes a well developed capillary system on the inner or 
mesodermal surface of the yolk sac (Snell, 1956). This circulatory 
system is separated from the maternal blood by Reichert's membrane 
and the yolk sac. It is suspected that Reichert's membrane 
plays a passive role in the transport of substances by acting 
as a semi-permeable membrane. As previously mentioned, the 
yolk sac probably actively absorbs the substances passed through 
Reichert's membrane and then passes them on to the fetal 
circulatory system. The results from the present study demonstrated 
that the yolk sac takes up a significantly greater amount of 
total label than the fetuses. Qualitatively there were no 
significant differences between the per cent of specific 
corticoids within the embryos and the yolk sac, with one exception 
to be discussed later. 
From these results, one could conclude that the yolk sac 
and the placenta act as a quantitative barrier to the fetuses. 
Most all of the results, both quantitative and qualitative, 
show no significant difference between the three fetal segments. 
This may indicate that the embryonic tissues have not, at this 
stage, developed the necessary enzyme systems for metabolism 
of cortisol. However, the higher per cent of cortisone in the 
fetal torso than either the jaws or head at the 2.0 hour interval 
may indicate the presence of 11-betahydroxysteroid dehydrogenase 
in the fetal liver. This enzyme has been shown to be the primary 
----
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catalyst necessary for the biotransformation of cortisol to 
~ 
cortisone in U.B.C. Swiss mice (Burton et al, 1967). Further 
support for the possibility of metabolism in the fetal liver 
in this study, was the observation that the per cent of cortisone 
within the torso was significantly higher than the cortisone 
per cent within the placenta at the 0.5, 1.0, 1.5, and 2.0 hour 
intervals. The observation of a significantly higher cortisone 
percent in the fetal jaws than in the yolk sac may be due to 
cortisone from the fetal liver reaching the jaws prior to the 
yolk sac in circulation. Whether these results represent 
differential binding of cortisone by the fetal liver and the 
placenta or the existance of active metabolism must be documented 
by further studies. 
Evidence of metabolism of cortisol in the fetal liver in 
vitro in U.B.C. mice was reported by Burton et al. The results 
presented indicate that a similar activity occurs in the fetal 
A/Jax mouse. 
E. The Uptake and Metabolism of Tritiated Cortisol in A/Jax Mouse 
Tissues 
The very high level of tritium found in the maternal liver 
at the 0.5 hour post-injection interval indicates a rapid 
absorption of the intramuscular injection of the tritiated 
cortisol. At this same time interval in the liver, significantly 
higher per cents of labeled conjugated (origin) and unconjugated 
(undetermined metabolites) metabolites than cortisol were identified 
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(Figure 7). Significant per cents of labeled cortisone were 
identified beginning at the 0.5 hour interval in the liver. It was 
also observed, that at all time intervals when the per cents 
of similar labeled corticoids in the placenta, yolk sac, and 
fetal tissues were not significantly different, the per cents 
of these same corticoids within the liver were significantly 
different when compared to the previous tissues. This indicated 
without doubt, that the majority of cortisol metabolism was 
occurring in the liver. 
The very high percentages of conjugated and unconjugated 
metabolites demonstrate the remarkable ability of the maternal 
liver to detoxify relatively large quantities of cortisol under 
the influence of a teratogenic dose of cortisone acetate. 
Increasingly high percentages of conjugated metabolites were 
detected in all other maternal tissues and in the fetuses. 
This indicates that the kidney was unable to eliminate these 
water soluble products from the blood stream as fast as the 
liver was producing them. Even though these products are not 
biologically active, they may be more toxic than cortisol or 
cortisone, especially to the sensitive embryonic tissues 
(Marx, 1973). Such reasoning points toward the need of a parallel 
study in which 3H-cortisol is injected without the influence 
of a teratogenic dose. Under more normal conditions, one might 
not expect to find these possibly toxic products overflowing 
past a placenta or yolk sac barrier into the fetal tissues. 
Another study should be conducted to test the teratogenic 
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ability of cortisol metabolites by injecting them into pregnant 
A/Jax mice. 
At the three hour interval, when equilibrium between the 
tissues was reached in the per cents of cortisol, cortisone and 
undetermined metabolites, the percent of conjugated metabolites 
was still significantly different between all of the tissues. 
This further demonstrated the kidney's inability to effectively 
eliminate the conjugated metabolites. 
F. Biotransformation of Cortisol to Cortisone 
The biotransformation of cortisol to cortisone in the maternal 
liver implies the presence of 11 beta-hydroxysteroid dehydrogenase. 
As indicated previously, this reaction is reversible. This may 
account for the reported findings that cortisol (Ingalls et al) 
and cortisone (Baxter et al) possess equal teratogenic abilities 
in the A/Jax mouse. It is reasonable to assume, that due to 
the reversible nature of these compounds in biologic systems 
and their similar functions, the mechanism of cleft palate 
induction in the fetuses is similar for both. 
As previously discussed, the possibility of conversion of 
cortisol to cortisone in the fetal liver may exist. However, 
incubation studies should be conducted to confirm this hypothesis. 
The significance of such a finding is, that the fetal liver may 
produce the very corticoid metabolites which are in turn teratogenic 
to the fetus. 
CHAPTER 6 
SUMMARY AND CONCLUSIONS 
Twenty-one pregnant A/Jax mice were intramuscularly injected 
with a solution of 50 uCi of 3H-cortisol and 10 mg. of cortisone 
acetate on day 12 of gestation. Four animals were sacrificed 
at each of the following time intervals after injection: 0.5 hour, 
l .0 hour, 1 .5 hours, 2.0 hours, 3.0 hours and one animal at 
6.0 hours. The maternal liver, adrenal, brain, placenta, 
yolk sac (extraembryonic) and the fetuses in three segments, 
torso, jaws, and the remainder of the head were removed for 
analysis. Each tissue was analyzed for total tritium content 
and the per cents of labelled cortisol and cortisol metabolites 
present. By oxidative combusion and liquid scintillation 
combined with thin-layer chromatography. 
l. Previous studies had not qualitatively identified the 
presence of maternally injected labeled corticoids in the fetal 
tissues of A/Jax mice. It was evident, from the results, that 
not only did the injected cortisol reach the fetal tissues, but 
significant per cents of cortisone and other cortisol metabolites 
could be identified from the 0.5 interval and remained significant 
through the 3.0 hour interval. 
2. The comparative results between fetuses, yolk sac, and 
the placenta indicate that both the yolk sac and placenta act as 
a quantitative 11 barrier 11 for the passage of certain corticoids. 
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3. Cortisol is significantly converted to cortisone in 
the A/Jax mouse. 
4. The fetal tissues do not significantly differ in the 
uptake of tritium label through 3.0 hours after injection. 
5. The fetal tissues do incorporate a significantly lower 
amount of total labeled corticoids than the maternal liver, 
adrenal, placenta, and yolk sac. 
CHAPTER 7 
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TABLE 1 
PREGNANT A/JAX MOUSE 6.0 HOURS POST-INJECTION 
Fetal Fetal Fetal 
Adrenal Brain Liver Placenta Yolk Sac Head Jaws Torso 
DPM/mg. of 764.6 8.5 636.2 164.8 957.3 115 .4 132 .1 82.9 
Tissues 
Chromatographic 
Zones in % 
Cortisone 9.8 9.8 11.0 11.1 8.8 7.9 11.1 7.3 
Cortisol 24.8 25.4 14.8 24.1 36.0 51.0 34.4 37.0 
Undetermined 
Metabolites 17.9 21.6 21.9 20.7 14.0 6.9 11.2 16.7 
Origin 15.7 15.9 42.0 19.3 9.3 5.6 10.8 8.7 
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CRT SOL 
ANOVA TABLE 46 
ADRENL 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN '+ 837.31 209.32 0.86 
TIME NONSIGNIFICANT 
WITHIN l'+ 3372.82 2'+0.91 
(P >.OS) 
Al\IIMAL 
TOTAL 18 '+210.13 
COMPARISONS OF MEANS K-VALUE 30.61 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 36.27 '+.39 1.5 HR-2.0 HR 19.17 
1. 0 HR 36.65 9.'+9 1.5 HR-3.0 HR 16.17 
1.5 HR '+9.07 18.27 .5 HR .. 1.5 HR 12.79 
2.0 HR 29.90 12.78 1.0 HR-1.5 HR 12.'f.2 
3.0 HR 32.90 27.85 1.0 HR•2.0 HR 6.75 
.5 HR-2.0 HR 6.37 
1.0 HR .. 3.0 HR 3.75 
.5 HR-3.0 HR 3.37 
2.0 HR .. 3.0 HR 3.00 
.5 HR .. 1.0 HR o.37 
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ANOVA TABLE 47 
BRAIN 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 520.26 130.06 1.09 
TIME NONSIGNIFICANT 
WITHIN 15 1781.03 118.73 
(P>.os) 
ANIMAL 
TOTAL 19 2301.30 
COMPARISONS OF MEANS K•VALUE 21.29 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 53.84 7.54 .5 HR-3.0 HR 16.00 
1.0 HR '+6.87 11.07 1.s HR-3.0 HR 9.35 
1.5 HR 47.20 2.88 1.0 HR-3.0 HR 9.02 
2.0 HR '+5.57 10.56 .5 HR-2.0 HR a.21 
3.0 HR 37.84 17.15 2.0 HR-3.0 HR 1.12 
.5 HR-1.0 HR 6.97 
.5 HR•l.5 HR 6.64 
1.5 HR-2.0 HR 1.62 
1.0 HR-2.0 HR le29 
1.0 HR-1.5 HR o.32 
100 
r 
CRT SOL 
ANOVA TABLE 48 
LIVER 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 132.37 33.09 1.93 
TIME NONSIGNIFICANT 
WITHIN 14 239.41 11.10 (P > .05) 
ANIMAL 
TOTAL 18 371.78 
COMPARISONS OF MEANS K-VALUE 8.15 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 17.60 3.'+1 .5 HR .. 3.0 HR 6.86 
1. 0 HR 15.20 5.89 .5 HR .. 2.0 HR 6.79 
1.5 HR 14.67 4.70 1.0 HR .. 3.0 HR 4.'+6 
2.0 HR 10.80 3.1'+ 1.0 HR•2.0 HR '+. 40 
3.0 HR 10.73 1.42 1.5 HR-3.0 HR 3. 9'f. 
1.5 HR•2.0 HR 3.87 
.5 HR-1.5 HR 2.92 
.5 HR•l.O HR 2.39 
1.0 HR-1.5 HR o.52 
2.0 HR-3.0 HR 0.06 
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ANOVA TABLE 49 
PL AC EN 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 773.63 193.40 2.68 
TIME NONSIGNIFICANT 
WITHIN 16 1153.29 72.08 
(P > .05) 
ANIMAL 
TOTAL 20 1926.93 
COMPARISONS OF MEANS K-VALUE 16.44 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 48.50 5.93 1.0 HR•3.0 HR 14.82 
1.0 HR 48.95 2.14 .5 HR•3.0 HR 14.38 
1.5 HR 47.27 2.15 1.5 HR-3.0 HR 13.15 
2.0 HR 39.65 0.47 1.0 HR•2.0 HR 9.29 
3.0 HR 34.12 15.96 .5 HR-2.0 HR a.as 
1.s HR-2.0 HR 7.62 
2.0 HR-3.0 HR s.53 
1.0 HR•l.5 HR 1.67 
.5 HR-1.5 HR 1.22 
.5 HR-1.0 HR o.44 
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ANOVA TABLE 50 
YLK SC 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 96.33 24.08 0.20 
TIME NONSIGNIFICANT 
(P >.OS) 
WITHIN 11 1299.68 118.15 
ANIMAL 
TOTAL 15 1396.01 
COMPARISONS OF MEANS K-VALUE 22.21 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 38.47 8.86 1.0 HR-1.5 HR 6.tf.3 
1.0 HR 35. tf.O 10. 7tf. 1.5 HR-3.0 HR 5.90 
1.5 HR tf.1.83 12.05 1.0 HR-2.0 HR 5.50 
2.0 HR 40.90 tf..68 2.0 HR-3.0 HR q.. 97 
3.0 HR 35.92 ltf.. 30 .5 HR-1.5 HR 3.35 
.5 HR-1.0 HR 3.07 
.5 HR .. 3.0 HR 2. 5tf. 
.5 HR-2.0 HR 2. tf.2 
1.5 HR-2.0 HR o.93 
1.0 HR-3.0 HR o.52 
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ANOVA TABLE 51 
ADRENL 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F·RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 257.44 64.36 0.80 
TIME NONSIGNIFICANT 
WITHIN 14 1118.19 79.87 
(P >.OS) 
ANIMAL 
TOTAL 18 1375.64 
COMPARISONS OF MEANS K .. VALUE 17.62 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS OIFF. 
.5 HR 11.92 5.20 2.0 HR•3.0 HR 11.44 
1.0 HR 8.17 3.06 1.0 HR•3.0 HR 8.12 
1.5 HR 11.34 6.31 .5 HR-2.0 HR 6.47 
2.0 HR 5.44 2.77 1.5 HR-2.0 HR 5.89 
3.0 HR 16.89 20.80 1.5 HR•3.0 HR 5.55 
.5 HR-3.0 HR 4.97 
.5 HR-1.0 HR 3.75 
1.0 HR•l.5 HR 3.17 
1.0 HR•2.0 HR 2.12 
.5 HR-1.5 HR o.57 
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SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 52 
DEGREES OF 
FREEDOM 
15 
19 
BRAIN 
SUM OF 
SQUARES 
96.62 
348.46 
445.08 
COMPARISONS OF 
MEAN 
SQUARE F-RATIO 
24.15 
23.23 
MEANS K-VALUE 
DECISION 
CONCERNING Ho 
ACCEPTED 
NONSIGNIFICANT 
(P >.OS) 
9.41 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
10. 47 2.88 1.5 HR-3.0 HR 6.09 
8.35 8.34 1.5 HR-2.0 HR 4.ao 
12.02 5.61 .5 HR-3.0 HR 4.55 
7.22 2.05 1.0 HR•l.5 HR 3.67 
5.92 1.54 .5 HR-2.0 HR 3.25 
1.0 HR-3.0 HR 2.42 
.s HR-1.0 HR 2.12 
.5 HR .. 1.5 HR 1.54 
2.0 HR-3.0 HR 1.30 
1.0 HR-2.0 HR 1.12 
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SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 53 
LIVER 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
4 11.83 2.95 2.84 
NONSIGNIFICANT 
14 14.52 1.03 (P >.OS) 
18 26.36 
COMPARISONS OF MEANS K•VALUE 2.00 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF • 
1.97 0.28 • 5 HR-3.0 HR 2.35 .5 HR-1.0 HR 1.90 
3.87 0.89 .5 HR•l.5 HR 1.50 
3.47 1.78 2.0 HR-3.0 HR 1.23 
3.09 0.64 .5 HR-2.0 HR 1.12 
4.33 0.12 1.5 HR-3.0 HR o.85 
1.0 HR•2.0 HR 0.11 
1.0 HR•3.0 HR o.45 
1.0 HR-1.5 HR 0.40 
1.5 HR-2.0 HR o.37 
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ANOVA TABLE 54 
PLACEN 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 4 337.76 84.44 6.26 
TIME SIGNIFICANT 
(P<. 01) 
WITHIN 16 215.78 13.48 
ANIMAL 
TOTAL 20 553.54 
COMPARISONS OF MEANS K-VALUE 1.11 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 21.90 4. 'f.5 .5 HR-3.0 HR 11.72 2.0 HR•3.0 HR q.. 5'f. 
1.0 HR 17.87 2.67 1.0 HR-3.0 HR 7.69 .5 HR-1.5 HR 'f. .40 
1.5 HR 17.50 4. 'f.8 1.5 HR-3.0 HR 7.32 .5 HR-1.0 HR 4.02 
2.0 HR 14.72 2.40 .5 HR-2.0 HR 1.11 1.0 HR-2.0 HR 3.15 
3.0 HR 10.17 3.77 1.5 HR-2.0 HR 2.11 
1.0 HR•l.5 HR o.37 
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SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 55 
YLK SC 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
4 610.39 152.59 15.19 
SIGNIFICANT 
11 110.48 10.04 
(P <.01) 
15 720.88 
COMPARISONS OF MEANS K•VALUE 6.lf-7 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
32.20 4.69 .5 HR-3.0 HR 15. 51.f. .5 HR-1.0 HR 6.19 
26.00 0.10 .5 HR-2.0 HR 14.33 2.0 HR-3.0 HR 1.21 
25.53 2.92 1.0 HR-3.0 HR 9.35 1.0 HR-1.5 HR o.46 
17.86 2.10 1.5 HR-3.0 HR a.ea 
16.65 2.44 1.0 HR-2.0 HR 8.13 
1.5 HR-2.0 HR 7.66 
.5 HR-1.5 HR 6.66 
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UNDMET 
SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOT.l\L 
.5 HR 
1,0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 56 
A ORE NL 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
ACCEPTED 
4 188.46 47.11 1.23 
NONSIGNIFICANT 
14 533.14 38.08 
(P>.05) 
18 721.60 
COMPARISONS OF MEANS K•VALUE 12.17 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
20.25 4.88 1.5 HR .. 3.0 HR 9.88 
18.27 7.35 .5 HR ... 1.5 HR 1.09 
13.14 3,82 1.0 HR-1.5 HR 5.12 
18.25 7.24 1.5 HR•2.0 HR 5.09 
23.03 6,99 2.0 HR•3.0 HR 4.78 
1.0 HR-3.0 HR 4.75 
.5 HR-3.0 HR 2.78 
.5 HR-2.0 HR 2.00 
.5 HR-1.0 HR 1.97 
1.0 HR•2.0 HR 0.02 
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ANOVA TABLE 57 
BRAIN 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 139.30 3Lf..82 0 .8Lf. 
TIME NONSIGNIFICANT 
(P >. 05) 
WITHIN 15 619.60 Lf.1.30 
ANIMAL 
TOTAL 19 758.90 
COMPARISONS OF MEANS K·VALUE 12.56 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 19 .Lf.2 8.10 .5 HR•l.5 HR 6.Lf.5 
1. 0 HR 19.52 9.81 1.0 HR-1.5 HR 6.35 
1.5 HR 25.87 2. OLf. .5 HR•2.0 HR 
"'· 92 2.0 HR 24.35 3.9'+ 1.0 HR-2.0 HR 4.82 
3.0 HR 23.82 '+.98 .5 HR-3.0 HR '+•'+0 
1.0 HR-3.0 HR t+.30 
1.5 HR-3.0 HR 2.04 
1.5 HR-2.0 HR 1.52 
2.0 HR-3.0 HR o.52 
.5 HR-1. 0 HR o.o9 
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SOURCE OF 
VARIATION 
BETWEEN 
TIME 
~!THIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 58 
LIVER 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
4 509.00 127.25 2.60 ACCEPTED 
NONSIGNIFICANT 
14 682.81 48.77 (P >. 05) 
18 1191.82 
COMPARISONS OF MEANS K00 VALUE 13.77 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
39.34 6.70 1.0 HR-1.5 HR 13.40 
46.34 9.13 1.0 HR-2.0 HR 13.35 
32.95 1.01 1.0 HR-3.0 HR 11.31 
33.00 4.64 .5 HR•l.O HR 1.00 
35.03 6.42 .5 HR•l.S HR 6.40 
.5 HR-2.0 HR 6.34 
.5 HR-3.0 HR 4.31 
1.s HR-3.0 HR 2.os 
2.0 HR-3.0 HR 2.03 
1.5 HR ... 2.0 HR o.o5 
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UNDMET 
SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 59 
DEGREES OF 
FREEDOM 
16 
20 
PLACEN 
SUM OF 
SQUARES 
504.52 
257.65 
762.18 
COMPARISONS OF 
MEAN 
SQUARE F-RATIO 
126.13 7.83 
16.10 
MEANS K-VALUE 
DECISION 
CONCERNING Ho 
REJECTED 
SIGNIFICANT 
(P <.Ol) 
1.11 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
15.22 3.12 .5 HR-3.0 HR 14.81 2.0 HR-3.0 HR 7.49 
23.89 2.79 1.5 HR-3.0 HR 8.69 .5 HR-2.0 HR 7.32 
21.35 4.92 .5 HR-1.0 HR 8.67 1.0 HR-3.0 HR 6.14 
22.54 4.15 .5 HR-1.5 HR 6.12 
30.04 4.48 1.0 HR•l.5 HR 2.54 
1.0 HR•2. 0 HR 1.34 
1.5 HR•2.0 HR 1.19 
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SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 60 
YLK SC 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
REJECTED 
4 363.75 90.93 5.11 
SIGNIFICANT 
(.OS>P ::>.Ol) 
11 195.46 17.76 
15 559.21 
COMPARISONS OF MEANS K-VALUE 8.61 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
11.55 2.44 .5 HR-3.0 HR 12.47 1.0 HR-3.0 HR 1.11 
16.85 8.41 1.5 HR-3.0 HR 9.45 1.5 HR-2.0 HR 5.83 
14.56 1.88 .5 HR-2.0 HR 8.85 .5 HR•l.O HR 5.30 
20.40 1.66 2.0 HR•3.0 HR 3.62 
24.02 5.60 1.0 HR•2.0 HR 3.54 
.5 HR•l.5 HR 3.01 
1.0 HR ... 1.5 HR 2.28 
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ANOVA TABLE 61 
ADRENL 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F·RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN ,,.. 1520.69 380.17 2.16 
TIME NONSIGNIFICANT 
WITHIN 1'+ 2459.85 175.70 (P >. 05) 
ANIMAL 
TOTAL 18 3980.5'+ 
COMPARISONS OF MEANS K•VALUE 26.1'+ 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 17.95 9.87 1.0 HR ... 2.0 HR 21+. 77 
1.0 HR 7.77 8.11 1.5 HR-2.0 HR 22.7'+ 
1.5 HR 9.80 11.59 2.0 HR-3.0 HR li+.61 
2.0 HR 32. 5'+ 20.52 .5 HR-2.0 HR 11+. 59 
3.0 HR 17.93 12.28 .5 HR-1.0 HR 10.11 
1.0 HR•3.0 HR 10.15 
,5 HR-1.5 HR 8.1'+ 
1.5 HR-3.0 HR 8.13 
1.0 HR•l.5 HR 2.02 
.5 HR-3.0 HR 0.01 
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ANOVA TABLE 62 
BRAIN 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
BETWEEN 4 507.89 126.97 3.46 REJECTED 
TIME SIGNIFICANT 
WITHIN 15 550.31 36.68 c.os>P>.01) 
ANIMAL 
TOTAL 19 1058.20 
COMPARISONS OF MEANS K ... VALUE 11.83 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 4.67 0.93 .5 HR-3.0 HR 13.79 .5 HR-1.0 HR 11.54 
1.0 HR 16.22 1.46 2.0 HR-3.0 HR 9.72 
1.5 HR 10.10 1.17 1.5 HR-3.0 HR a.37 
2.0 HR 8.75 9.29 1.0 HR•2.0 HR 7.47 
3.0 HR 18.47 9.62 1.0 HR-1.5 HR 6.12 
.5 HR•l.5 HR 5.1+2 
.5 HR-2.0 HR 4.01 
1.0 HR ... 3.0 HR 2.25 
1.5 HR-2.0 HR 1.35 
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' 
ORIGIN 
ANOVA TABLE 63 
LIVER 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 811.77 202.94 3.03 
TIME NONSIGNIFICANT 
(P >.05) 
WITHIN 14 936.56 66.89 
ANIMAL 
TOTAL 18 1748.34 
COMPARISONS OF MEANS K-VALUE 16.13 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS OIFF. COMPARISONS OIFF. 
.5 HR 37.57 4.69 1.0 HR-2.0 HR 17.97 1.0 HR-3.0 HR 14.93 
1.0 HR 29.89 13.91 1.0 HR .. 1.5 HR 14.29 
1.5 HR 44.20 5.46 .5 HR-2.0 HR 10.29 
2.0 HR 47.87 7.44 .5 HR .. 1.0 HR 7.67 
3.0 HR 44.83 4.10 .5 HR .. 3.0 HR 7.25 
.5 HR•l.5 HR 6.62 
1.5 HR ... 2.0 HR 3.67 
2.0 HR-3.0 HR 3.04 
1.5 HR-3.0 HR o.63 
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ORIGIN 
ANOVA TABLE 64 
PLACEN 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
ACCEPTED 
BETWEEN 4 950.34 237.58 2.85 
TIME NONSIGNIFICANT 
(P >.05) 
WITHIN 16 1330.14 83.13 
ANIMAL 
TOTAL 20 2280.49 
COMPARISONS OF MEANS K•VALUE 17.65 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
.5 HR 6.22 1.53 1.0 HR•3.0 HR 17.23 
1.0 HR 3.95 1.33 .5 HR-3.0 HR 14.95 
1.5 HR 8.42 4.27 1.5 HR ... 3.0 HR 12.75 
2.0 HR 16.65 5.46 1.0 HR-2.0 HR 12.10 
3.0 HR 21.17 17.12 .5 HR-2.0 HR 10.42 
1.5 HR-2.0 HR 8.22 
2.0 HR .. 3.0 HR 4.52 
1.0 HR•l.5 HR 4.47 
.5 HR-1.0 HR 2.27 
.5 HR-1.5 HR 2.19 
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ORIGIN 
SOURCE OF 
VARIATION 
BETWEEN 
TIME 
WITHIN 
ANIMAL 
TOTAL 
.5 HR 
1.0 HR 
1.5 HR 
2.0 HR 
3.0 HR 
ANOVA TABLE 65 
YLK SC 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
4 456.37 114.09 3.48 REJECTED 
SIGNIFICANT 
11 360.47 32.77 < .os>P > .01) 
15 816.84 
COMPARISONS OF MEANS K-VALUE 11.69 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
4.85 2.62 1.0 HR-3.0 HR 13.67 .5 HR-2.0 HR l0.31 
2.90 o.oo 1.0 HR-2.0 HR 12.26 1.0 HR-1.5 HR 7.33 
10.23 7.50 .5 HR-3.0 HR 11.72 1.5 HR-3.0 HR 6.3lf. 
15.16 3.13 .5 HR ... 1.5 HR 5.38 
16.57 8.31 1.5 HR•2.0 HR 4.93 
.5 HR-1.0 HR 1.95 
2.0 HR-3.0 HR 1.40 
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ADRENL 
A NOVA TABLE 66 
.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 1296.42 432.14 10.29 
ME TAB. SIGNIFICANT 
WITHIN 12 503.47 
(P< .01) 
41.95 
ANIMAL 
TOTAL 15 1799.89 
COMPARISONS OF MEANS K•VALUE 13.60 
SIGNIF. RANKED MEAN NON ... SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRTSON 11.92 5.20 CRTSON•CRTSOL 24.35 CRTSON•UNDMET a.32 
CRT SOL 36.27 4.39 CRTSOL .. ORIGIN 18.32 CRTSON•ORIGIN 6.02 
UNDMET 20.25 4.88 CRTSOL ... UNDMET 16.02 UNDMET•ORIGIN 2.29 
ORIGIN 17.95 9.87 
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ADRENL 
ANOVA TABLE 67 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F·RATIO CONCERNING Ho 
BETWEEN 3 2194.65 731.55 13.32 
REJECTED 
ME TAB. SIGNIFICANT 
WITHIN 12 658.89 54.90 
(P<.Ol) 
ANIMAL 
TOTAL 15 2853.54 
COMPARISONS OF MEANS K•VALUE 15.56 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON a.11 3.06 CRTSOL-ORIGIN 28.87 UNDMET•ORIGIN 10.50 
CRTSOL 36.65 9.49 CRTSON•CRTSOL 28.47 CRTSON•UNDMET 10.10 
UNDMET 18.27 7.35 CRTSOL 00 UNDMET 18.37 CRTSON•ORIGIN o.39 
ORIGIN 1.11 a.11 
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...... 
ADRENL 
ANOVA TABLE 68 
1.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 4273.17 1424.39 10.89 
MET AB. SIGNIFICANT 
(P <. 01) 
WITHIN 12 1569.38 130.78 
ANIMAL 
TOTAL 15 5842.55 
COMPARISONS OF MEANS K•VALUE 2Lf.. 01 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRTSON 11.34 6.31 CRTSOL-ORIGIN 39.27 UNDMET-ORIGIN 3.3'+ 
CRTSOL 49.07 18.27 CRTSON-CRTSOL 37.72 CRTSON•UNDMET 1.ao 
UNDMET 13.14 3.82 CRTSOL-UNDMET 35.92 CRTSON•ORIGIN 1.54 
ORIGIN 9.80 11.59 
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ADRENL 
ANOVA TABLE 69 
2.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 181f.3.28 614.42 3.81 
MET AB. SIGNIFICANT 
WITHIN 12 1934.85 161.23 
(.OS:>P>.Ol) 
ANIMAL 
TOTAL 15 3778.13 
COMPARISONS OF MEANS K-VALUE 26.66 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 5.44 2.77 CRTSON-ORIGIN 27.09 CRTSON-CRTSOL 24.'f.5 
CRT SOL 29.90 12.78 UNDMET•ORIGIN 14.29 
UNDMET 18.25 7.24 CRTSON•UNDMET 12.ao 
ORIGIN 32.54 20.52 CRTSOL•UNDMET 11.65 
CRTSOL-ORIGIN 2.6'f. 
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AORENL 
ANOVA TABLE 70 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
BETWEEN 3 481.53 160.51 0.45 
ACCEl'TED 
MET AB. NONSIGNI'FICANT 
~JI THIN 8 2817.41 352.17 (P >.05) 
ANIMAL 
TOTAL 11 3298.94 
COMPARISONS OF MEANS K•VALUE 42.50 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS PIFF. 
CRT SON 16.89 20.80 CRTSON•CRTSOL 16.00 
CRT SOL 32.90 27.85 CRTSOL-ORIGIN 14.96 
UNDMET 23.03 6.99 CRTSOL•UNDMET 9.86 
ORIGIN 17.93 12.28 CRTSON•UNDMET (,.13 
UNDMET-ORIGIN 5.10 
CRTSON-ORIGIN 1.03 
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BRAIN 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRT SOL 
UNDMET 
ORIGIN 
ANO VA TABLE 71 
.s HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
REJECTED 
3 5815.95 1938.65 58.89 
SIGNIFICANT 
12 395.01 32.91 
(P <.Ol) 
15 6210.96 
COMPARISONS OF MEANS K•VALUE 12.0'+ 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
10.'+7 2.88 CRTSOL-ORIGIN '+9.17 CRTSON•UNOMET a.9'+ 
53.8'+ 7.5'+ CRTSON 00 CRTSOL 43. 37 CRTSON-ORIGIN 5.80 
19.'+2 8.10 CRTSOL 00 UNDMET 3'+. 42 
4.67 0.93 UNDMET-ORIGIN 1'+. 7'+ 
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BRAIN 
ANOVA TABLE 72 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 3369.'+0 1123.13 15.'+4 
METAB. SIGNIFICANT 
WITHIN 12 872.35 72.69 
(P< .01) 
ANIMAL 
TOTAL 15 '+241.75 
COMPARISONS OF MEANS K•VALUE 17.90 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 8.35 8.3'+ CRTSON•CRTSOL 38.52 CRTSON-UNDMET 11.11 
CRT SOL '+6.87 11.01 CRTSOL-ORIGIN 30.65 CRTSON-ORIGIN 1.a1 
UNDMET 19.52 9.81 CRTSOL-UNDMET 27.35 UNDMET•ORIGIN 3.29 
ORIGIN 16.22 1.'+6 
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BRAIN 
SOURCE OF 
VARIATION 
BETWEEN 
METAB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRTSOL 
UNDMET 
ORIGIN 
ANOVA TABLE 73 
1.5 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
12.02 
'+7.20 
25.87 
10.10 
3 
12 
15 
REJECTED 
3512.82 1170.9'+ 103.0'+ 
SIGNIFICANT 
(P <. 01) 
136.35 11.36 
3649.18 
COMPARISONS OF MEANS K-VALUE 7.07 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
5.61 CRTSOL-ORIGIN 
2.88 CRTSON-CRTSOL 
2.0'+ CRTSOL•UNDMET 
1.17 UNDMET•ORIGIN 
CRTSON-UNDMET 
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37.10 CRTSON-ORIGIN 
35.17 
21.32 
15.77 
13.85 
MEAN 
DIFF. 
1.92 
BRAIN 
ANOVA TABLE 74 
2.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATIOl\I FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 3816.25 1272.08 23.36 
MET AB. SIGNIFICANT 
WITHIN 12 653.29 5'+. '+'+ 
(P <. 01) 
ANIMAL 
TOTAL 15 '+'+69.55 
COMPARISONS OF MEANS K•VALUE 15.49 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 7.22 2.05 CRTSON-CRTSOL 38.35 CRTSON•ORIGIN 1.52 
CRTSOL Lf.5.57 10.56 CRTSOL-ORIGIN 36.82 
UNDMET 21.f..35 3.9'+ CRTSOL-UNDMET 21.22 
ORIGIN 8.75 9.29 CRTSON-UNDMET 17.12 
UNDMET-ORIGIN 15.60 
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BRAIN 
ANOVA TABLE 75 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 2097.83 699.27 6.75 
MET AB. SIGNIFICANT 
WITHIN 12 1242.39 103.53 
(P'<. 01) 
ANIMAL 
TOTAL 15 3340.22 
COMPARISONS OF MEANS K,.VALUE 21.36 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRTSON 5.92 1. 54 CRTSON-CRTSOL 31.92 CRTSOL-ORIGIN 19.37 
CRT SOL 37 .84 17.15 CRTSON-UNDMET 17.90 
UNDMET 23.82 4. 98 CRTSOL•UNDMET 14. 02 
ORIGIN 18.Lf.7 9.62 CRTSON-ORIGIN 12. 54 
UNDMET-ORIGIN 5.35 
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LIVER 
SOURCE OF 
VARIATION 
BETWEEN 
METAB. 
WITHIN 
ANIMAL 
TOTAL 
CRTSON 
CRT SOL 
UNDMET 
ORIGIN 
A NOVA TABLE 76 
.5 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATJO CONCERNING Ho 
MEAN 
1.97 
17.60 
39.34 
37.57 
3 
12 
15 
1261.20 REJECTED 3783.60 64.14 
SIGNIFICANT 
235.94 19.66 (P <. 01) 
4019.55 
COMPARISONS OF MEANS K-VALUE 9.31 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
0.28 CRTSON-UNDMET 
3.41 CRTSON-ORIGIN 
6.70 CRTSOL-UNDMET 
4.69 CRTSOL-ORIGIN 
CRTSON .. CRTSOL 
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37.37 UNDMET-ORIGIN 
35.60 
21.75 
19.97 
15.62 
MEAN 
DIFF. 
1.11 
LIVER 
ANOVA TABLE 77 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 '+066.69 1355.56 17.33 
MET AB. SIGNIFICANT 
WITHIN 12 938.29 78.19 
(P <.Ol) 
ANIMAL 
TOTAL 15 500'+.99 
COMPARISONS OF MEANS K-VALUE 18.56 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 3.87 0.89 CRTSON-UNDMET '+2.47 UNDMET-ORIGIN 16.45 
CRT SOL 15.20 5.89 CRTSOL-UNDMET 31.1'+ CRTSOL-ORIGIN lt+.69 
UNDMET 46.3'+ 9.13 CRTSON-ORIGIN 26.02 CRTSON-CRTSOL 11.32 
ORIGIN 29.89 13.91 
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LIVER 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRT SOL 
UNDMET 
ORIGIN 
ANOVA TABLE 78 
1.5 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
3.'+7 
1'+.67 
32.95 
'+'+.20 
3 
12 
15 
REJECTED 3985.00 1328.33 50.'+9 
SIGNIFICANT 
315.68 26.30 (P <:. 01) 
'+300.69 
COMPARISONS OF MEANS K-VALUE 10.77 
SIGNIF. RANKED 
STD. COMPARISONS 
1.78 CRTSON-ORIGIN 
'+.70 CRTSOL-ORIGIN 
7.07 CRTSON-UNDMET 
5.'+6 CRTSOL•UNDMET 
UNDMET-ORIGIN 
CRTSON-CRTSOL 
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MEAN 
DIFF. 
'+0.72 
29.52 
29.'+7 
18.27 
11.25 
11.20 
NON-SIGNIF. 
COMPARISONS 
MEAN 
DIFF. 
LIVER 
ANOVA TABLE 79 
2.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNHJG Ho 
REJECTED 
BETWEEN 3 5046.76 1682.25 77.00 
MET AB. SIGNIFICANT 
(P <.Ol) 
WITHIN 12 262.16 21.84 
ANIMAL 
TOTAL 15 5308.92 
COMPARISONS OF MEANS K-VALUE 9.81 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRTSON 3.09 0.64 CRTSON-ORIGIN 44.77 CRTSON-CRTSOL 7.70 
CRT SOL 10.80 3.14 CRTSOL-ORIGIN 37.07 
UNDMET 33.00 4.64 CRTSON-UNDMET 29.89 
ORIGIN 47.87 7.44 CRTSOL-UNDMET 22.20 
UNDMET-ORIGIN 14.87 
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LIVER 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRT SOL 
UNDMET 
ORIGIN 
ANOVA TABLE 80 
3.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
'+. 33 
10.73 
35.03 
44.83 
3 
8 
11 
REJECTED 
3354.77 1118.25 73.79 
SIGNIFICANT 
(P <.Ol) 
121.22 15.15 
3476.00 
COMPARISONS OF MEANS K-VALUE 8.81 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
0.72 CRTSON-ORIGIN 
1.42 CRTSOL-ORIGIN 
6.42 CRTSON-UNDMET 
4.10 CRTSOL-UNDMET 
UNDMET-ORIGIN 
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40.50 CRTSON•CRTSOL 
34.10 
30.70 
24.29 
9.80 
MEAN 
DIFF. 
6.39 
PLACEN 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRTSON 
CRT SOL 
UNDMET 
ORIGIN 
A NOVA TABLE 81 
.5 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
21.90 
48.50 
15.22 
6.22 
3 
12 
15 
REJECTED 
3973.22 1324.40 78.82 
SIGNIFICANT 
(P <. 01) 
201.63 16.80 
4174.85 
COMPARISONS OF MEANS K-VALUE 8.60 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
4.45 CRTSOL-ORIGIN 
5.93 CRTSOL-UNDMET 
3.12 CRTSON-CRTSOL 
1.53 CRTSON•ORIGIN 
UNDMET•ORIGIN 
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42.27 CRTSON-UNDMET 
33.27 
26.60 
15.67 
9.00 
MEAN 
DIFF. 
6.67 
PLACEN 
ANOVA TABLE 82 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 4246.36 1415.45 265.36 
MET AB. SIGNIFICANT 
(P <.Ol) 
WITHIN 12 64.00 5.33 
ANIMAL 
TOTAL 15 4310.37 
COMPARISONS OF MEANS K-VALUE 4.85 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRTSON 17.87 2.67 CRTSOL-ORIGIN 45.00 
CRTSOL 48.95 2.14 CRTSON-CRTSOL 31.07 
UNDMET 23.89 2.79 CRTSOL·UNDMET 25.04 
ORIGIN 3.95 1.33 UNDMET-ORIGIN 19.95 
CRTSON-ORIGIN 13.92 
CRTSON-UNOMET 6.02 
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PLACEN 
ANOVA TABLE 83 
1.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 3332.21 1110.73 66.00 
METAB. SIGNIFICANT 
(P < .01) 
WITHIN 12 201.92 16.82 
ANIMAL 
TOTAL 15 3531+.13 
COMPARISONS OF MEANS K-VALUE 8.61 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 17.50 I+ .1+8 CRTSOL-ORIGIN 38.85 CRTSON-UNDMET 3.85 
CRTSOL 1+7.27 2.15 CRTSON-CRTSOL 29.77 
UNO MET 21.35 '+.92 CRTSOL-UNDMET 25.92 
ORIGIN 8 .1+2 '+.27 UNDMET-ORIGIN 12.92 
CRTSON-ORIGIN 9.07 
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PLACEN 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRT SOL 
UNOMET 
ORIGIN 
ANOVA TABLE 84 
2.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
3 1542.41 514.13 38.70 
SIGNIFICANT 
12 159.39 13.28 
(P< .01) 
15 1701.80 
COMPARISONS OF MEANS K-VALUE 7.65 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
14.72 2.40 CRTSON-CRTSOL 24.92 UNDMET ... QRIGIN 5.89 
39.65 0.47 CRTSOL-ORIGIN 23.00 CRTSON-ORIGIN 1.92 
22.54 4.15 CRTSOL-UNDMET 17.10 
16.65 5.46 CRTSON-UNDMET 7.82 
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PLACEN 
ANOVA TABLE 85 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 1688.91 562.97 3.86 
MET AB. SIGNIFICANT 
WITHIN 16 2329.91 1'+5.61 
(.OS>P >.Ol) 
ANIMAL 
TOTAL 19 '+018.83 
COMPARISONS OF MEANS K-VALUE 2£+.. '+3 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 10.17 3.77 CRTSON-CRTSOL 23.9'+ 
CRTSOL 3'+.12 15.96 CRTSON-UNDMET 19.86 
UNDMET 30.0'+ '+.'+8 CRTSQL .. QRIGIN 12.9'+ 
ORIGIN 21.17 17.12 CRTSON•ORIGIN 11.00 
UNDMET-ORIGIN a.a6 
CRTSOL-UNDMET Lf..07 
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YLK SC 
A NOVA TABLE 86 
.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 3114.30 1038.10 36.62 
METAB. SIGNIFICANT 
(P < .01) 
WITHIN 12 340.16 28 .3Lf. 
ANIMAL 
TOTAL 15 3Lf.54.47 
COMPARISONS OF MEANS K•VALUE 11.18 
SIGNIF. RANKED MEAN NON .. SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 32.20 4.69 CRTSOL-ORIGIN 33.62 UNDMET•ORIGIN 6.69 
CRT SOL 38.47 8.86 CRTSON•ORIGIN 27.34 CRTSON-CRTSOL 6.27 
UNDMET 11.55 2.44 CRTSOL-UNDMET 26.92 
ORIGIN 4.85 2.62 CRTSON-UNDMET 20.64 
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YLK SC 
ANOVA TABLE 87 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F•RATIO CONCERNING Ho 
BETWEEN 1150.32 383.44 8.20 REJECTED 3 
MET AB. SIGNIFICANT 
WITHIN 4 186.82 46.70 (.OS>P>.OI) 
ANIMAL 
TOTAL 7 1337.14 
COMPARISONS OF MEANS K·VALUE 19.68 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 26.00 0.10 CRTSOL•ORIGIN 32.50 CRTSOL-UNDMET 18.54 
CRT SOL 35.40 10.74 CRTSON-ORIGIN 23.10 UNDMET•ORIGIN 13.95 
UNDMET 16.85 8.41 CRTSON•CRTSOL 9.39 
ORIGIN 2.90 o.oo CRTSON-UNDMET 9.15 
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YLK SC 
ANOVA TABLE 88 
1.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BEn~EEN 3 1785.64 595.21 11.13 
METAB. SIGNIFICANT 
WITHIN 8 '+27.62 53.'+5 
(P <. 01) 
ANIMAL 
TOTAL 11 2213.26 
COMPARISONS OF MEANS K-VALUE 16.55 
SIGNIF. RANKED MEAN NON·SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 25.53 2.92 CRTSOL-ORIGIN 31.60 CRTSON-CRTSOL 16.29 
CRT SOL '+1.83 12.05 CRTSOL-UNDMET 27.26 CRTSON-ORIGIN 15.30 
UNDMET 1'+.56 1.88 CRTSON-UNDMET 10.96 
ORIGIN 10.23 7.50 UNDMET .. QRIGIN i+.33 
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YLK SC 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRTSON 
CRTSOL 
UNDMET 
ORIGIN 
ANOVA TABLE 89 
2.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
3 1240.56 413.52 42.42 
SIGNIFICANT 
(P<.Ol) 
8 77.97 9.74 
11 1318.53 
COMPARISONS OF MEANS K•VALUE 7.07 
SIGNIF. RANKED 
MEAN STD. COMPARISONS 
17.86 
40.90 
20.40 
15.16 
2.10 CRTSOL-ORIGIN 
4.68 CRTSON .. CRTSOL 
1.66 CRTSOL•UNDMET 
3.13 
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MEAN 
DIFF. 
25.73 
23.03 
20.50 
NON-SIGNIF. MEAN 
COMPARISONS DIFF. 
UNDMET .. QRIGIN s.23 
CRTSON-ORIGIN 2.69 
CRTSON-UNDMET 2.53 
YLK SC 
ANOVA TABLE 90 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 997.45 332.48 'f-. 27 
MET AB. SIGNIFICANT 
(.OS>P>.Ol) 
WITHIN 12 933.51 77.79 
ANIMAL 
TOTAL 15 1930.96 
COMPARISONS OF MEANS K•VALUE 18.52 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRTSON 16.65 2.44 CRTSOL-ORIGIN 19.35 CRTSOL•UNDMET 11.90 
CRTSOL 35.92 14.30 CRTSON-CRTSOL 19.27 UNDMET-ORIGIN 7.45 
UNO MET 24.02 5.60 CRTSON-UNDMET 7.37 
ORIGIN 16.57 8.31 CRTSON-ORIGIN 0.01 
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HEAD 
A NOVA TABLE 91 
.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
BETWEEN 3 3407.73 REJECTED 1135.91 9.96 
ME TAB. SIGNIFICANT 
WITHIN 12 1367.72 113.97 (P < .01) 
ANIMAL 
TOTAL 15 4775.45 
COMPARISONS OF MEANS K-VALUE 22.41 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 31.44 14.53 CRTSOL-ORIGIN 35.55 CRTSON-UNDMET 20.97 
CRT SOL 38.50 15.20 CRTSON-ORIGIN 28.50 UNDMET•ORIGIN 7.52 
UNDMET 10.47 3.25 CRTSOL-UNDMET 28.02 CRTSON•CRTSOL 1.05 
ORIGIN 2.95 1.67 
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HEAD 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
wITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRT SOL 
UNDMET 
ORIGIN 
ANOVA TABLE 92 
1.0 HR 
MEAN DECISION DEGREES OF 
FREEDOM 
SUM OF 
SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
24.29 
41.52 
20.97 
2.67 
3 
12 
15 
REJECTED 
3041.91 1013.97 44.69 
SIGNIFICANT 
(P < .01) 
272.26 22.68 
3314.17 
COMPARISONS OF MEANS K-VALUE 10.00 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
STD. COMPARISONS DIFF. COMPARISONS DIFF. 
4.92 CRTSOL-ORIGIN 38.85 CRTSON-UNDMET 3.32 
4.62 CRTSON-ORIGIN 21.62 
6.45 CRTSOL-UNDMET 20.55 
1.84 UNDMET-ORIGIN 18.29 
CRTSON-CRTSOL 17.22 
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HEAD 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRT SOL 
UNDMET 
ORIGIN 
ANOVA TABLE 93 
1.5 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING H-o 
MEAN 
23.72 
35.67 
16.67 
6.12 
3 
12 
15 
REJECTED 
181.f.7.77 615.92 31.06 
SIGNIFICANT 
(P <, 01) 
237.91 19.82 
2085.68 
COMPARISONS OF MEANS K-VALUE 9.35 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
7.Lf.O CRTSOL-ORIGIN 
2.08 CRTSOL-UNDMET 
'+.Lf.3 CRTSON-ORIGIN 
0.68 CRTSON-CRTSOL 
UNDMET-ORIGIN 
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29.55 CRTSON-UNDMET 
19.00 
17.60 
11.95 
10.55 
MEAN 
DIFF. 
1. 01.f. 
HEAD 
SOURCE OF 
VARIATION 
BETWEEN 
METAB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRTSOL 
UNDMET 
ORIGIN 
ANOVA TABLE 94 
2.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
17.07 
37.42 
15.67 
11.80 
3 
12 
15 
1588.62 529.54 19.98 REJECTED 
SIGNIFICANT 
318.00 26.50 (P <.Ol) 
1906.62 
COMPARISONS OF MEANS K-VALUE 10.81 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
STD. COMPARISONS DIFF. COMPARISONS DIFF. 
3.66 CRTSOL-ORIGIN 25.62 CRTSON-ORIGIN 5.21 
8.33 CRTSOL-UNDMET 21.75 UNDMET•ORIGIN 3.87 
1.94 CRTSON·CRTSOL 20.35 CRTSON•UNDMET 1.40 
4.40 
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HEAD 
ANOVA TABLE 95 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 4208.23 1402.7'+ 24.51 
MET AB. SIGNIFICANT 
(P< .01) 
WITHIN 12 686.69 57.22 
ANIMAL 
TOTAL 15 4894.92 
COMPARISONS OF MEANS K .. VALUE 15.88 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 12.62 5.35 CRTSOL-ORIGIN '+1.42 UNDMET-ORIGIN l0.30 
CRTSOL 49.55 11.58 CRTSON-CRTSOL 36.92 CRTSON-UNDMET 5.80 
UNDMET 18.42 7.25 CRTSOL•UNDMET 31.12 CRTSON-ORIGIN 4.50 
ORIGIN 8.12 3.65 
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JAWS 
ANOVA TABLE 96 
.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F ... RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 3586.90 1195.63 22.40 
MET AB. SIGNIFICANT 
WITHIN 12 640.37 53.36 
(P <.Ol) 
ANIMAL 
TOTAL 15 4227.27 
COMPARISONS OF MEANS K-VALUE 15.34 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 31.89 8.63 CRTSOL•ORIGIN 37.12 UNOMET-ORIGIN e.52 
CRTSOL 40.12 11.71 CRTSON-ORIGIN 28.90 CRTSON-CRTSOL a.22 
UNDMET 11.52 1.15 CRTSOL•UNDMET 28.60 
ORIGIN 3.00 o.57 CRTSON-UNDMET 20.37 
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JAWS 
ANOVA TABLE 97 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 1813.95 60'+.65 21. 08 
MET AB. SIGNIFICANT 
WITHIN '+ 11'+.72 28.68 
(P <:.01) 
ANIMAL 
TOTAL 7 1928.68 
COMPARISONS OF MEANS K•VALUE 15.'+2 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 19.95 1.90 CRTSOL-ORIGIN '+0.15 CRTSON-ORIGIN 13.60 
CRTSOL '+6.50 7.63 CRTSOL-UNDMET 32.10 UNDMET-ORIGIN a.os 
UNDMET 1'+.'+0 '+.80 CRTSON-CRTSOL 26.54 CRTSON-UNDMET 5.55 
ORIGIN 6.35 5.'+'+ 
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JAWS 
SOURCE OF 
VJ.\.RIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRTSON 
CRTSOL 
UNDMET 
ORIGIN 
ANOVA TABLE 98 
1.5 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
23.57 
'+2.59 
16.92 
5.69 
3 
12 
15 
REJECTED 
2872.50 957.50 '+3.26 
SIGNIFICANT 
(P<.Ol) 
265.59 22.13 
3138 .• 10 
COMPARISONS OF MEANS K-VALUE 9.87 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
3.96 CRTSOL-ORIGIN 
5.81 CRTSOL-UNDMET 
5.91 CRTSON-CRTSOL 
1.99 CRTSON-ORIGIN 
UNDMET-ORIGIN 
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36.90 CRTSON•UNDMET 
25.67 
19.02 
17.87 
11.22 
MEAN 
DIFF. 
6.65 
JAWS 
ANOVA TABLE 99 
2.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 2421.71 807.23 9.23 
MET AB. SIGNIFICANT 
WITHIN 8 699.01 87.37 
(P <.Ol) 
ANIMAL 
TOTAL 11 3120.73 
COMPARISONS OF MEANS K•VALUE 21.17 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 12.60 1.86 CRTSOL-ORIGIN 38.13 UNDMET•ORIGIN 11.26 
CRT SOL 41.53 18.07 CRTSON-CRTSOL 28.93 CRTSON-ORIGIN 9.20 
UNDMET 14.66 3.26 CRTSOL-UNDMET 26.86 CRTSON-UNDMET 2.06 
ORIGIN 3.39 2.95 
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JAWS 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRT SOL 
UNO MET 
ORIGIN 
Al'JOVA TABLE 100 
3.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
12.22 
42.57 
20.67 
12.17 
3 
12 
15 
REJECTED 
2468.54 822.84 18.86 
SIGNIFICANT 
523.33 43.61 
(P <.Ol) 
2991.87 
COMPARISONS OF MEANS K-VALUE 13.86 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
STD. COMPARISONS DIFF. COMPARISONS DIFF. 
2.55 CRTSOL-ORIGIN 30.40 UNDMET•ORIGIN a.so 
9.00 CRTSON-CRTSOL 30.35 CRTSON•UNDMET a.44 
5.43 CRTSOL-UNDMET 21.90 CRTSON-ORIGIN o.os 
7.56 
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TORSO 
ANOVA TABLE 101 
.5 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 3209.41 1069.80 19.22 
MET AB. SIGNIFICANT 
WITHIN 12 667.61 55.63 
(P < .01) 
ANIMAL 
TOTAL 15 3877.03 
COMPARISONS OF MEANS K-VALUE 15.66 
SIGNIF. RANKED MEAN NON-SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 37.09 12.00 CRTSON-ORIGIN 33.42 UNDMET-ORIGIN 9.42 
CRT SOL 34.62 7.03 CRTSOL-ORIGIN 30.95 CRTSON•CRTSOL 2.47 
UNDMET 13.09 4.65 CRTSON-UNDMET 21.f..OO 
ORIGIN 3.67 2.10 CRTSOL-UNDMET 21.52 
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TORSO 
ANOVA TABLE 102 
1.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F .. RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 2841.13 947.04 31.53 
MET AB. SIGNIFICANT 
WITHIN 12 360.38 30.03 
(P <.Ol) 
ANIMAL 
TOTAL 15 3201.51 
COMPARISONS OF MEANS K•VALUE 11.50 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRTSON 27.99 6.85 CRTSOL•ORIGIN 36.57 CRTSON .. CRTSOL 10.62 
CRT SOL 38.62 4.89 CRTSON·ORIGIN 25.94 CRTSON•UNDMET 6.84 
UNDMET 21.11+ 6.94 UNDMET .. ORIGIN 19.10 
ORIGIN 2.05 0.97 CRTSOL-UNDMET 17.47 
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TORSO 
SOURCE OF 
VARIATION 
BETWEEN 
MET AB. 
WITHIN 
ANIMAL 
TOTAL 
CRT SON 
CRTSOL 
UNDMET 
ORIGIN 
ANOVA TABLE 103 
1.5 HR 
DEGREES OF 
FREEDOM 
SUM OF 
SQUARES 
MEAN 
SQUARE F-RATIO 
DECISION 
CONCERNING Ho 
REJECTED 
MEAN 
28.15 
39.72 
18.90 
4.52 
3 
12 
15 
2657.04 885.68 55.71 
SIGNIFICANT 
(P <.Ol) 
190.74 15.89 
2847.78 
COMPARISONS OF MEANS K-VALUE 8.37 
SIGNIF. RANKED MEAN NON-SIGNIF. 
STD. COMPARISONS DIFF. COMPARISONS 
5.56 CRTSOL•ORIGIN 
1.48 CRTSON-ORIGIN 
4.97 CRTSOL-UNDMET 
2.38 UNDMET•ORIGIN 
CRTSON•CRTSOL 
CRTSON-UNDMET 
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35.20 
23.62 
20.82 
14.37 
11.57 
9.25 
MEAN 
DIFF. 
TORSO 
SOURCE OF 
VARIATION 
BETWEEN 
ME TAB. 
WITHIN 
ANIMAL 
TOTAL 
CRTSON 
CRT SOL 
UNO MET 
ORIGIN 
ANOVA TABLE 104 
2.0 HR 
DEGREES OF SUM OF MEAN DECISION 
FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
MEAN 
22.45 
41.77 
20.72 
5.97 
3 
12 
15 
REJECTED 
2590.16 863.38 35.87 
SIGNIFICANT 
288.81 2'+.06 
(P <.Ol) 
2878.97 
COMPARISONS OF MEANS K-VALUE 10.30 
SIGNIF. RANKED MEAN NON .. SIGNIF. MEAN 
STD. COMPARISONS DIFF. COMPARISONS DIFF. 
'+. 5'+ CRTSOL-ORIGIN 35.80 CRTSON•UNDMET 1.12 
7.78 CRTSOL•UNDMET 21.05 
3.13 CRT SON-CRT SOL 19.32 
2.27 CRTSON-ORIGIN 16.'+7 
UNDMET-ORIGIN 1'+. 7'+ 
157 
TORSO 
ANOVA TABLE 105 
3.0 HR 
SOURCE OF DEGREES OF SUM OF MEAN DECISION 
VARIATION FREEDOM SQUARES SQUARE F-RATIO CONCERNING Ho 
REJECTED 
BETWEEN 3 1688.06 562.68 '+ .1 7 
MET AB. SIGNIFICANT 
(.05>P>.Ol) 
WITHIN 12 1616.21 13'+.68 
ANIMAL 
TOTAL 15 330'+.27 
COMPARISONS OF MEANS K-VALUE 2'+.37 
SIGNIF. RANKED MEAN NON•SIGNIF. MEAN 
MEAN STD. COMPARISONS DIFF. COMPARISONS DIFF. 
CRT SON 15.89 3.19 CRTSOL-ORIGIN 26.65 CRTSON-CRTSOL 23.25 
CRT SOL 39.15 18.0'+ CRTSOL-UNDMET 15.35 
UNDMET 23.79 9.87 UNDMET-ORIGIN 11.30 
ORIGIN 12.50 10.26 CRTSON-UNDMET 7.89 
CRTSON•ORIGIN 3.Lf.O 
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